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Abstract 
This report is the outcome of an EFSA procurement (NP/EFSA/GMO/2018/01) reviewing 
relevant scientific information on in silico prediction methods for protein toxicity, that could 
support the food and feed risk assessment. Several proteins are associated with adverse (toxic) 
effects in humans and animals, by a variety of mechanisms. These are produced by plants, 
animals and bacteria to prevail in hostile environments. In the present report, we present an 
integrated pipeline to perform a comprehensive literature and database search applied to 
proteins with toxic effects. “Toxin activity” and “toxin-antitoxin system” strings were used as 
inputs for this pipeline. UniProtKB was considered as the reference database, and only the 
UniProtKB curator-reviewed proteins were considered in the pipeline. Experimentally-
determined structures and homology-based in silico 3D models were retrieved from protein 
structures repositories; family-, domain-, motif- and other molecular signature-related 
information was also obtained from specific databases which are part of the InterPro 
consortium. Protein aggregation associated with adverse effects was also investigated using 
different search strategies. This work can serve as the basis for further exploring novel risk 
assessment strategies for new proteins using in silico predictive methods.  
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1. Introduction 
1.1. Background and Terms of Reference as provided by the requestor 
This report is the outcome of a contract titled “Literature search – exploring in silico protein toxicity 
prediction methods to support the food and feed risk assessment” (reference number 
NP/EFSA/GMO/2018/01), awarded by the European Food Safety Authority (EFSA) to the Università degli 
Studi di Milano. The following tasks were defined by EFSA. 
1.1.1. Task 1 
 The contractor will perform a comprehensive literature search to identify and retrieve all related 
information/data published in peer-reviewed literature, including public protein databases, regarding 
proteins causing adverse effects (“toxic” proteins) in humans and animals (mammals, fish and birds). 
 The contractor will describe the above identified proteins with regards to their biochemical, functional 
and structural properties and will detail the type of adverse effects occurring in humans and animals 
(mammals, fish and birds). The pathogenesis leading to the adverse effect(s) will be described, 
providing information on the underlying molecular mechanism of action(s), when known.  
 The contractor will also provide detailed information on any identified molecular signatures (e.g. 
motifs, domains) associated with the above identified proteins. Moreover, the contractor will describe 
the role of these signatures in the context of Mode of Action or Adverse Outcome Pathway, whenever 
available.  
1.1.2. Task 2 
The contractor will provide a description (e.g. data sources used, curation methods, algorithms 
employed) and an evaluation (e.g. quality of curation methods, reliability of search options, user-
friendliness) of the available in silico resources containing information on molecular signatures 
associated with protein toxicity (e.g. general databases such as InterPro, Protein Data Bank or PFAM 
databases or more specific tools such as the KNOTTIN database).  
1.2. Interpretation of the Terms of Reference as provided by EFSA 
Extensive and up-to-date information on proteins, including toxins, with accurate, consistent and rich 
annotation is contained in the UniProt protein database which can considered the most comprehensive 
protein database (Bateman et al., 2017). Therefore, it was decided to base and stem the search strategy 
to address Task 1 on this database. Together with UniProt, literature databases were also then used to 
expand the search. An automated tool (Python-based script) was developed to retrieve and manage all 
the information and to develop an in silico pipeline, and it is provided to EFSA.  
Moreover, preliminary work and discussion with EFSA identified the need to expand the scope of Task 
1 to investigate proteins that may misfold, aggregate and/or polymerize under specific circumstances, 
causing pathological effects. With this aim and in agreement with EFSA, aggregates was identified as a 
term covering proteins that could be putatively classified as toxic under certain circumstances. Due to 
the expansion of the original question it was necessary to set new definitions and new methodologies 
to address this specific aspect (see Section 1.3.2). 
1.3. Protein toxicity – Background information 
Some proteins can cause adverse effects in humans and animals, via a variety of mechanisms and in a 
variety of settings (Dang and Van Damme, 2015; Franceschi et al., 2017; Lucas et al., 2018). In the 
scientific literature the term ‘toxic proteins’ generally refers to proteins of exogenous origin capable of 
causing adverse effects to human beings or animals in a context of an offence/defence paradigm. Some 
human or animal endogenous proteins are also capable to induce adverse effects following 
polymerisation or misfolding in particular conditions (i.e. proteins with putative toxic activity as 
aggregates). These two categories are further described and exemplified in Sections 1.3.1 and 1.3.2 
below.  
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1.3.1. Toxic proteins 
Based on Gene Ontology (GO)1 definition of toxin activity, toxic proteins (or toxins) can be defined as 
proteins that interact selectively with one or more biological molecules in another organism (the "target" 
organism), initiating pathogenesis (leading to an abnormal, generally detrimental state) in the target 
organism. 
Various plants, animals and bacteria produce toxic proteins to prevail in hostile environments. The toxic 
activity of such proteins is achieved via a variety of mechanisms. For the purpose of this report it was 
considered useful to cluster toxins into two groups: 
 proteins causing toxic effects per se, acting as monomers or homo-multimers; these toxic 
proteins can be found in animal venoms, in plants and in bacteria; these are also referred in 
the context of this report as proteins with a well-recognised toxic activity; 
 toxins acting in the context of toxin-antitoxin systems, i.e. proteins causing a toxic effect only 
in case of perturbation of the toxin and antitoxin concentration equilibrium. These toxins are 
found only in bacteria.  
Examples of proteins from the two groups are provided below in Section 1.3.1.1 and 1.3.1.2. 
1.3.1.1. Proteins causing toxic effects per se 
In plants toxic proteins have been identified throughout the plant kingdom and have also been found 
in edible crops; in the literature, they are sometimes defined with the alternative terms “antinutritional 
factors”, or “antinutrients”, since their ingestion can lead to interference in the absorption of nutrients.  
For example, lectins are a superfamily of proteins selectively binding carbohydrates and functioning as 
recognition molecules in cell–molecule and cell–cell interactions in a variety of biological systems 
(Sharon and Lis, 2004; Miyake et al., 2007). They typically agglutinate certain animal cells and/or 
precipitate glycoconjugates. Lectins have been reported in legumes, tomato, potato, banana and garlic, 
and the ingestion of legumes containing high levels of certain lectins may be associated with 
gastrointestinal effects in humans and animals (Noah et al., 1980; Rodhouse et al., 1990; Bardocz et 
al., 1995; Grant et al., 1995). The LC(50) of the lectin alpha chain of Dioclea grandiflora is 2.52 µg/ml 
against the brine shrimp A.salina.  
Ribosome inactivating proteins (such as ricin) showing N-glycosidase activity have been identified in 
several edible plants, including pumpkin, cucumber, beet, and cereals (Dang and Van Damme, 2015; 
Parisi et al., 2018; Vandenborre et al., 2011). They act as glycosidases that remove a specific adenine 
residue from an exposed loop of the 28S rRNA (A4324 in mammals), leading to rRNA breakage. As this 
loop is involved in elongation factor binding, modified ribosomes are catalytically inactive and unable to 
support protein synthesis. Each protein can inactivate a few thousand ribosomes per minute, faster than 
the cell can make new ones. Therefore, a single molecule can kill an animal cell.   
Protease inhibitors/α-amylase inhibitors are widely distributed in plants, mainly in storage tissues.  
Thionins are cysteine-containing proteins present in a number of monocot and dicot plants causing 
increased cellular membrane permeability. They possess antifungal activity sensitive to inorganic 
cations, inducing potential changes in fungal membranes and increased K+ efflux and Ca2+ uptake.  
Cyclotides and other pore-forming toxins are also described in plants.  
Toxic proteins of animal origin are typically secreted in animal venoms, such as those of snakes, 
spiders, scorpions, cone snails, jellyfish, insects, sea anemones, lizards, a few fish and platypuses 
(Masood et al., 2018; Tasoulis and Isbister, 2017). These can exert their detrimental effects via their 
enzymatic activity (e.g. acidic phospholipase A2 RV-7of Eastern Russel’s viper) or act as neurotoxins 
(e.g. basic phospholipase A2 ammodytoxin C of Western sand vipera). Some of these poisonous animals 
use venom injection systems in their predatory behaviour. Poisonous animals that lack venom injection 
systems, such as certain mammals, toads, ticks and worms, rely on toxins as an effective defence 
                                                 
1 Gene Ontology is the main database for classifying proteins basing on their function. See Section 2.1.2 for further details. 
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against predation. A specific section in UniProt is devoted to animal toxin annotation 
(https://www.uniprot.org/program/Toxins). Modes of action (MoA) of these animal toxins are very 
diversified. As an example of MoA, we report that of phospholipase A2 P-elapitoxin-Aa1a alpha chain of 
Acanthophis antarcticus, whose heterotrimer inhibits nerve-evoked twitch contractions but not 
responses to cholinergic agonists acetylcholine and carbachol and to depolarizing agonist KCl. 
Among bacterial toxic proteins there are tetanus, botulinum, and diphtheria toxins, which are relevant 
in human and animal pathology. Some bacterial toxic proteins are entomopathogenic, showing 
specificity to target species. Bacillus thuringiensis is a Gram positive, spore-forming bacterium that 
synthesizes parasporal crystalline inclusions containing Cry and Cyt proteins that have been successfully 
used as bioinsecticides (Yuan et al., 2019). It expresses the crystal protein Cry that promotes 
colloidosmotic lysis by binding to the midgut epithelial cells of insects. 
1.3.1.2. Toxin-antitoxin systems 
Toxin-antitoxin (TA) systems are molecular modules that are ubiquitous in free-living prokaryotes. 
Diverse in structure and function, TA loci comprise two genes, usually encoded in a single operon, either 
in the bacterial chromosome or in plasmids: one of them encodes for a stable toxin whose 
overexpression kills the cell or causes growth stasis; the other gene encodes for an unstable antitoxin 
that counteracts toxin action. The systematic balancing of the levels of expression and the interactions 
between toxins and antitoxins allows a number of adaptive outcomes, including stress tolerance, 
virulence, phage defence, and biofilm formation. Under basal conditions, the two components together 
do not cause any harm; accordingly, they are not associated with ‘toxic activity’ and deserve to be 
investigated and referred to separately from toxins causing toxic effects per se described above such 
as those of animal or vegetal origin already commented on. At the state-of-the-art, six types of TA 
systems are known (Durand et al., 2012 and Figure 1):  
 Type I TA system. Toxin synthesis is inhibited by antisense RNA that forms base pairs with toxin 
mRNA. In this type of system, the toxin generally affects cellular membrane integrity, in turn 
impairing essential cellular functions such as cell division. 
 Type II TA system. Both the toxin and antitoxin are proteins. The toxin activity is inhibited by 
the antitoxin by forming the TA complex. Under unfavourable conditions, cellular proteases are 
activated and degrade the antitoxin, which releases the toxin. 
  Type III TA system. The toxin protein is bound to the antitoxin RNA, forming the RNA 
pseudoknot–toxin complex. When complexed, the toxin is inactivated. 
  Type IV TA system. Both the toxin and antitoxin are proteins: the protein toxin destabilizes 
filamentous cytoskeleton proteins and inhibits cell division, whereas the antitoxin protein 
stabilizes filamentous cytoskeleton proteins. 
  Type V TA system. The toxin peptide is involved in membrane lysis while the antitoxin is a 
ribonuclease specific for the toxin mRNA.  
  Type VI TA system. Both the toxin and antitoxin are proteins. In the absence of the antitoxin, 
the toxin binds to the sliding clamp and inhibits DNA replication.  
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Figure 1: Models representing the interaction between toxins and antitoxins in the different types of 
toxin-antitoxin (TA) systems. 
1.3.2. Proteins with putative toxic activity as aggregates 
In the scientific literature the term ‘toxic proteins’ is also used for endogenous proteins owing a cellular 
biological role distinct from the offence/defence paradigm typical of exogenous toxins. This is due to 
the fact that these proteins may form structured or unstructured aggregates in tissues showing 
pathological conditions. The aggregation event may occur under specific conditions (including aging) 
either with the wild-type form or with pathological genetic variants. It is noteworthy that extensive 
investigations conducted in humans on these phenomena did not allow to establish a clear cause-effect 
relationship between the aggregation processes and the pathological conditions in all cases (Forloni and 
Balducci, 2018).  
In general, these proteins show an abnormal folding behaviour, failing to correctly fold into stable 3D 
structures; this is often associated with sequence mutations. This is for instance the case of the Z variant 
of the plasma protease inhibitor alpha-1-antitrypsin, that – due to a charge inversion mutation, 
Glu342Lys – forms polymeric assemblies in the endoplasmic reticulum of hepatocytes instead of 
proceeding through the secretion pathway and be released into the plasma and systemic circulation. 
This leads to the accumulation of insoluble deposits of aggregated proteins in the liver, with functional 
tissue substituted by cirrhotic nodules; in parallel, a decreased plasmatic level of alpha-1-antitrypsin 
diminishes antiprotease protection in various tissues, with subsequent disease conditions (e.g. 
pulmonary emphysema) (Gooptu and Lomas, 2009; Huang et al., 2016; Lucas et al., 2018).  
This is also the case of transthyretin, a tetrameric protein, composed of subunits in alpha/beta secondary 
structure. This protein is mainly synthesised in the liver and it is primarily responsible for the transport 
of thyroxin and of retinol through its complex with retinol binding protein, to different parts of the body 
and brain. Some genetic variants of transthyretin form unstable quaternary assemblies and, after 
dissociation, each subunit rearranges to an all-beta structure able to extensively interact with other 
similar monomers, eventually resulting in insoluble amyloid fibrils mainly in the nervous system and in 
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the heart. Such event may occur even with non-mutated transthyretin, in elderly people (senile systemic 
amyloidosis) (Benson, 2012; Saraiva, 2001).  
The causes of aggregation into amyloid fibrils for some proteins in their wild-type structure seem to be 
related to their abnormally high concentration in tissues, often secondary to a pre-existing disease (high 
synthesis, reduced catabolism or disposal); and to the declining ability of aging tissues to either promote 
refolding of misfolded proteins (through the chaperones) or to dispose of them (through the 
proteasome) (Comenzo, 2006; Iadanza et al., 2018; Nativi-Nicolau and Maurer, 2018; Soto and 
Pritzkow, 2018). Examples of all these types of pathology-association have been documented; some are 
listed hereafter. Among the proteins with a tendency to form amyloid deposits, other than alpha-1-
antitrypsin and transthyretin, are for instance atrial natriuretic factor (typical of senile amyloidosis of 
heart atria), beta-amyloid from amyloid precursor protein (typical of Alzheimer’s disease), 
immunoglobulin light chains (in cases of multiple myeloma), serum amyloid A (in the course of 
inflammation), prolactin (in patients with prolactinoma), calcitonin (in patients with medullary carcinoma 
of the thyroid), beta-2-microglobulin (in dialysis patients), amylin (in diabetic patients), mutants of 
apolipoprotein A-I, fibrinogen alpha-chain or lysozyme (in familial renal amyloidosis) (Bratosiewicz-
Wasik et al., 2004; Nativi-Nicolau and Maurer, 2018).   
Another protein that belongs to the category of endogenous compounds described as “toxic” is the prion 
(PrP) (Bratosiewicz-Wasik et al., 2004; Soto and Pritzkow, 2018). PrPC is a constitutive protein present 
in the cell membranes. Familial, sporadic or acquired prion diseases are described.  Familial and sporadic 
prion diseases are associated with the presence of mutated PrP. Acquired prion disease is associated 
with “infection” via ingestion. The infectious isoform of PrP, known as PrPSc, is able to convert PrPC 
proteins into PrPSc by changing their conformation from the normal alpha-helix structure to a higher 
proportion of beta-sheet. Aggregations of these abnormal isoforms form highly structured amyloid 
fibres, which accumulate to form plaques. The significance of PrPs has been highlighted following the 
emergence of bovine spongiform encephalopathy (BSE) as a major cattle disease in the United Kingdom. 
The onset of this disease was attributed to the feeding of cattle with meat- and bone-meal prepared 
from the carcasses of scrapie-infected sheep. Scrapie is also caused by prion proteins, as is the human 
equivalent - variant Creutzfeldt-Jakob disease (vCJD). The incidence of vCJD in humans has been linked 
to the consumption of BSE-infected beef. This association drove to extensive and stringent legislation 
in the European Union concerning the use of specified animal products in livestock feeding 
(Bratosiewicz-Wasik et al., 2004; Costanzo and Zurzolo, 2013). In the present work, the endogenous 
proteins above described are grouped under the heading of proteins with putative toxic activity as 
aggregates. 
2. Data and Methodologies 
The primary search for toxic proteins was based on the GO definition of “toxin activity”, i.e. proteins 
that interact selectively with one or more biological molecules in another organism (the "target" 
organism), initiating pathogenesis (leading to an abnormal, generally detrimental state) in the target 
organism. The activity should refer to an evolved function of the active gene product, i.e. one that was 
selected for. This search was then expanded into a secondary search using the “toxin-antitoxin 
system” (TAS) string. The above two searches were integrated with searches on 3D structures and 
families, domains and signatures of the identified proteins, giving rise to the Main Collection and to the 
Toxin-Antitoxin System (TAS) Collection, respectively. A Python-based software was created to manage 
all the information retrieved on the identified toxic proteins and associated literature. The in silico 
pipeline developed to address the EFSA Tasks is presented in Figure 2.  
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Figure 2: In silico pipeline devised to fulfil the EFSA request. 
Furthermore, the main freely available on-line tools for predicting protein toxicity were carefully tested 
to evaluate their performance. 
In addition, based on a preliminary work searching Pubmed with the search string “protein toxicity” and 
discussion with EFSA, proteins with putative toxic activity as aggregates were identified. These 
were treated separately, and specific definitions and methodologies to address this specific issue were 
set (Section 2.2.2). Details on the databases used and on the searching strategies are described in 
Sections 2.1 -2.5 below. 
2.1. Databases  
To perform a comprehensive search and to retrieve all the related information, peer-reviewed literature 
databases (Section 2.1.1) and protein databases containing information on protein primary structure 
and function (Section 2.1.2) were consulted. These databases were used for all the searches on toxic 
proteins (i.e. proteins showing toxin activity or belonging to toxin-antitoxin system) and on aggregates. 
To integrate the outcome of the above searches with information on the 3D structures and families, 
domains and signatures2, additional databases were consulted (Sections 2.1.3 and 2.1.4). These 
databases contain information on toxic proteins as defined above and therefore were used only for toxin 
activity and toxin-antitoxin system proteins. Further details on these databases can be found in the 
respective web pages (see links in paragraphs below).  
Section 2.1.5 briefly describes the toxin prediction tools available and the tests conducted to evaluate 
their performance in predicting the toxicity of unknown proteins. 
2.1.1. Literature databases 
The ‘Web of Science’, ‘Scopus’ and ‘Pubmed’ databases (Table 1) were used to search for publications 
(both primary research and review articles) providing information on the review questions.  
Table 1: Information sources used in the carried out extensive literature searches. 
Source Link 
Web of ScienceTM www.webofknowledge.com 
Scopus www.scopus.com 
PubMed www.ncbi.nlm.nih.gov/pubmed/ 
These databases are regarded as comprehensive sources of information by the scientific community 
(Figure 3) and were thus used to search for both toxic proteins and aggregates. 
                                                 
2 In the present report the term “signature” is used to describe a specific sequence pattern, motif or fingerprint, according to 
EMBL definition. Signatures inform on conserved residues that may be essential for stability or function of the protein. 
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Figure 3: Literature databases sources diagram. 
Below a brief description extracted from the webpage of each source used for the literature search. 
WEB OF SCIENCETM CORE COLLECTION (Clarivate Analytics) 
Web of ScienceTM Core Collection provides multidisciplinary content covering over 12,000 of the highest 
impact journals worldwide (including open access journals) and over 160,000 conference proceedings. 
The collection features current and retrospective coverage in the sciences, social sciences, arts, and 
humanities, with coverage dating back to 1900.  
SCOPUS (Elsevier) 
More than 60 million records are indexed in Scopus, including over 21,500 peer-reviewed journals, of 
which more than 4,200 are full open access. Scopus indexes also articles-in-press (i.e., articles that 
have been accepted for publication) from more than 5,000 international publishers. 
PUBMED (NCBI) 
PubMed comprises over 25 million citations for biomedical literature from MEDLINE, life science journals, 
and online books. PubMed citations and abstracts include the fields of biomedicine and health, covering 
portions of the life sciences, behavioural sciences, chemical sciences, and bioengineering. PubMed also 
provides access to additional relevant web sites and links to the other NCBI molecular biology resources. 
2.1.2. Protein Databases - Primary structure and function 
The most important protein information databases UniProt and GO (Table 2) were used to search for 
keywords feeding the review questions. These two databases were used to search for both toxic proteins 
and aggregates. In fact, UniProt is the gold standard source of information for proteins, while GO is the 
main database for classifying proteins based on their function. These two databases are interconnected, 
since UniProt contains the GO classification but it does not contain the GO definitions. 
Table 2: Information sources used in the carried out extensive primary structure searches. 
Source Link 
UNIPROT www.uniprot.org 
GENE ONTOLOGY www.geneontology.org 
The paragraphs below provide a brief description of these databases, extracted from the Uniprot and 
GO webpages. Further details on these databases can be found in their respective webpage (see links 
in Table 2). 
UNIPROT 
Uniprot (Consortium, 2008) is a freely accessible database whose mission is to provide the scientific 
community with a comprehensive, high-quality and freely accessible resource of protein sequence and 
functional information, with many entries being derived from genome sequencing projects. UniProt is 
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composed of three core (sub)databases: UniProtKB (with sub-parts Swiss-Prot and TrEMBL), UniParc 
and UniRef. In particular, the Swiss-Prot repository contains manually annotated and reviewed records 
with information extracted from literature and curator-evaluated computational analysis.  
A schematic representation of the Uniprot database is shown in Figure 4. 
 
Figure 4: Schematic representation of the UniProt database. 
GENE ONTOLOGY  
The Gene Ontology (GO) knowledgebase (Ashburner et al., 2000; Carbon et al., 2019) is the world’s 
largest source of information on the functions of genes. The mission of the GO Consortium is to develop 
a comprehensive, computational model of biological systems, ranging from the molecular to the 
organism level, across the multiplicity of species in the tree of life. The ontology covers three domains: 
biological processes, molecular functions and cellular components.  
A schematic representation of the GO database is shown in Figure 5. 
 
Figure 5: Schematic representation of the GO database. 
2.1.3.  Protein databases - Modelling tools 
The databases containing 3D protein structures (either experimentally derived or predicted based on 
homology modelling) that were used in this report are listed in Table 3. The ‘Protein Data Bank (PDB)’ 
is the reference database for all experimentally determined structures, whereas the ‘Swiss-Model’ 
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repository is a reference database for predicted models. In addition, ‘CPH MODEL’ is one of the most 
relevant, freely available tools for peptide and protein modelling. As indicated above, these 3D-structure 
oriented databases were used to search only for toxic proteins (toxin activity and toxin-antitoxin system 
searches). A brief description of these databases is provided below; this is extracted from the respective 
webpages, where further information can be found (see links in Table 3).  
Table 3: Information sources used for 3D structure searches. 
Source Link 
Protein Data Bank www.rcsb.org 
Swiss-Model www.swissmodel.expasy.org 
CPH MODEL www.cbs.dtu.dk/services/CPHmodels/ 
PROTEIN DATA BANK  
The PDB archive (Berman et al., 2002; Burley et al., 2019) is a repository of atomic coordinates and 
other information describing proteins and other important biological macromolecules. Methods such as 
X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy are used to determine the 
location of each atom relative to each other in the molecule. This information is deposited, annotated 
and publicly released into the archive by the wwPDB. 
SWISS-MODEL  
SWISS-MODEL (Benkert et al., 2011; Bienert et al., 2017; Waterhouse et al., 2018) is a structural 
bioinformatics web-server dedicated to homology modelling of 3D protein structures. Homology 
modelling is currently the most accurate method to generate reliable three-dimensional protein structure 
models and is routinely used in many practical applications. Homology (or comparative) modelling 
methods make use of experimental protein structures ("templates") to build models for evolutionary 
related proteins ("targets"). 
CPH MODEL SERVER  
CPH models 3.2 (Nielsen et al., 2010) is a protein homology modelling server. The template recognition 
is based on profile-profile alignment guided by secondary structure and exposure predictions. The CPH 
models is an easy to use web server for comparative protein homology modelling.  
2.1.4. Families, domains and signatures 
Protein-families, domains- and signatures-related databases used in this report are listed in Table 4 and 
are described below. All the listed databases are interconnected under the InterPro consortium, which 
classifies proteins into families, domains and other important motifs/sites (e.g. binding sites) and 
provides protein functional information for each entry based on those classifications. In fact, although 
the databases are independent of each other, the InterPro consortium is a collector of this information, 
especially with regards to domains. InterPro provides information both original and derived from the 
Consortium members. At the state of the art, InterPro is the most important database (Li et al., 2015) 
to classify protein domains and signatures while Pfam is the most important database for protein family 
classification (Finn et al., 2016). InterPro and Pfam are overlapping databases since a Pfam member (a 
family of proteins) can contain one or more InterPro entries (domains). To get the broadest view, we 
used both the databases, although some of the data are recurrent between the two of them. As above 
indicated, these databases were used only for toxic proteins (toxin activity and toxin-antitoxin system 
searches). Further details on these databases can be found in their respective web page (see links in 
Table 4). 
Table 4: Information sources used to carry out the domains, families and signatures searches. 
Source Link 
Interpro https://www.ebi.ac.uk/interpro/beta/ 
Pfam http://pfam.xfam.org 
PROSITE https://prosite.expasy.org 
CATH-GENE3D http://www.cathdb.info 
SUPFAM http://supfam.org 
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PRINTS http://130.88.97.239/PRINTS/index.php 
SMART http://smart.embl-heidelberg.de 
PANTHER http://pantherdb.org 
TIGRFAMS https://www.jcvi.org/research/tigrfams 
PIRSF https://proteininformationresource.org/pirwww/dbinfo/pirsf.shtml 
CDD https://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml 
INTERPRO  
InterPro (Goujon et al., 2010; Li et al., 2015) is a database of protein families, domains and functional 
sites, in which identifiable features found in known proteins can be applied to new protein sequences 
in order to functionally characterize them. The contents of InterPro consist of diagnostic signatures and 
the proteins that they significantly match. Additional information such as a description, consistent names 
and Gene Ontology (GO) terms, are associated with each entry. 
In particular, InterPro integrates predictive signatures representing functional sites into a single resource 
from a number of family and domain databases: Gene3D, PANTHER, Pfam, PIRSF, PRINTS, ProDom, 
PROSITE, SMART, SUPERFAMILY and TIGRFAMs. InterPro uses a pattern-based approach to classify 
the signatures and the information it contains was curator-evaluated.  
PFAM 
Pfam (Finn et al., 2016) is a database of protein families that includes their annotations and multiple 
sequence alignments generated using hidden Markov models. Pfam is produced at the European 
Bioinformatics Institute using a sequence database called Pfamseq, which is based on UniProtKB.  
PROSITE  
PROSITE (de Castro et al., 2006; Hulo et al., 2008; Sigrist et al., 2013, 2002)is a protein database that 
consists of entries describing the protein families, domains and functional sites as well as amino acid 
patterns and profiles in them. PROSITE's uses include identifying possible functions of newly discovered 
proteins and analysis of known proteins for previously undetermined activity. Properties from well-
studied genes can be propagated to biologically related organisms and, for different or poorly known 
genes, biochemical functions can be predicted from similarities. PROSITE uses tools for protein sequence 
analysis and motif detection. 
CATH-GENE3D  
CATH-Gene3D (Dawson et al., 2017) describes protein families and domain architectures in complete 
genomes. Protein families are formed using a Markov clustering algorithm, followed by multi-linkage 
clustering according to sequence identity. Mapping of predicted structure and sequence domains is 
undertaken using hidden Markov models libraries representing CATH and Pfam domains. 
SUPFAM  
SUPERFAMILY (Wilson et al., 2009) is a database of structural and functional annotation for all proteins 
and genomes. It classifies amino acid sequences into known structural domains. Domains are functional, 
structural, and evolutionary units that form proteins. Domains of common ancestry are grouped into 
superfamilies. Superfamilies are groups of proteins which have structural evidence to support a common 
evolutionary ancestor but may not have detectable sequence homology. 
PRINTS  
The PRINTS (Attwood et al., 1994) database houses a collection of protein family “fingerprints”. It 
provides both a detailed annotation resource for protein families and a diagnostic tool for newly 
determined sequences. A fingerprint is a group of conserved motifs taken from a multiple sequence 
alignment - together, the motifs form a characteristic signature for the aligned protein family. The 
diagnostic strength of fingerprints consists in their ability to distinguish sequence differences at the clan, 
superfamily, family and subfamily levels. This allows functional diagnoses of uncharacterized sequences, 
allowing discrimination between family members based on the ligands they bind or the proteins with 
which they interact. 
SMART  
SMART (Simple Modular Architecture Research Tool) (Carnate and Ed, 2008) is a biological database 
that is used in the identification and analysis of protein domains within protein sequences. SMART uses 
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profile-hidden Markov models built from multiple sequence alignments to detect protein domains in 
protein sequences. The most recent release of SMART contains 1,204 domain models. 
PANTHER  
PANTHER (Protein ANalysis THrough Evolutionary Relationships) (Thomas et al., 2003) is a large 
collection of protein families that have been subdivided into functionally related subfamilies. The 
subfamilies model the divergence of specific functions within protein families, allowing more accurate 
association with function as well as inference of amino acids important for functional specificity. Hidden 
Markov models (HMMs) are built for each family and subfamily for classifying additional protein 
sequences. 
TIGRFAMs  
TIGRFAMs (Haft et al., 2013) is a database of protein families designed to support manual and 
automated genome annotation. Each entry includes a multiple sequence alignment and hidden Markov 
model (HMM) built from the alignment. Sequences that score above the defined cut-offs of a given 
TIGRFAMs HMM are assigned to that protein family and may be assigned the corresponding annotations. 
TIGRFAMs uses the HMMER package; the current version has 4488 models. 
PIRSF  
The primary PIRSF (Nikolskaya et al., 2006) classification unit is the homeomorphic family, whose 
members are both homologous (evolved from a common ancestor) and homeomorphic (sharing full-
length sequence similarity and a common domain architecture). 
CDD  
CDD (Conserved Domain Database) (Marchler-Bauer et al., 2017) consists of a collection of well-
annotated multiple sequence alignment models for ancient domains and full-length proteins. These are 
available as position-specific score matrices (PSSMs) for fast identification of conserved domains in 
protein sequences via RPS-BLAST. CDD content includes domains, which use 3D-structure information 
to define domain boundaries and provide insights into sequence, structure, and function relationships. 
2.1.5. Toxin predicting tools 
Using the keywords from previous searches and adding “tool” and/or “prediction” terms, we selected 
the main freely available on-line tools (Table 5) from both a web search and the available scientific 
literature. Deprecated or not documented tools were discarded. These tools were carefully tested using 
both Main and TAS Collections in order to evaluate their performance in toxins prediction. A brief 
description of these tools is provided below; this is extracted from the respective webpages, where 
further information can be found (see links in Table 5). 
Table 5: Toxin predictors - Selected tools 
Source Link 
NTXpred http://crdd.osdd.net/raghava/ntxpred/ 
BTXpred http://crdd.osdd.net/raghava/btxpred/ 
KNOTTIN http://www.dsimb.inserm.fr/KNOTTIN/ 
CLANTOX http://www.clantox.cs.huji.ac.il 
CONOSERVER http://www.conoserver.org 
ToxinPred https://webs.iiitd.edu.in/raghava/toxinpred/index.html 
NTXpred 
The aim of NTXpred server is to predict neurotoxins and their probable function from primary amino 
acid sequence using SVM based on composition and PSI-Blast. Neurotoxins are key players in science 
and medicine and are used in ion channels and receptor studies, drug discovery, and formulation of 
insecticides. 
BTXpred 
The aim of BTXpred server is to predict bacterial toxins and their function from primary amino acid 
sequence using SVM, HMM and PSI-Blast. Bacterial toxins play a major role in causing disease and are 
responsible for the majority of symptoms and lesions during infections. 
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KNOTTIN 
This tool predicts whether a protein is a knottin, using the primary (Knotter1D) or the 3D (Knotter3D) 
structures of the query. It is also able to build knottin models (Knotter1D3D).  
CLANTOX 
ClanTox is a classifier of animal toxins that, given a protein sequence, tries to predict whether it 
represents a toxin or a toxin-like protein. The output of ClanTox is reported as a pair of numbers: the 
mean score and the standard deviation.  
CONOSERVER 
CONOSERVER is a database specializing in sequence and structure of conopeptides, which are peptides 
expressed by carnivorous marine cone snails. Conopeptides are classified into disulfide rich (conotoxins) 
and several classes of disulfide poor peptides. The database uses three different schemes to classify 
conotoxins.  
ToxinPred 
ToxinPred is an in silico method, developed to predict and design toxic/non-toxic peptides. The main 
dataset used in this method consists of 1805 toxic peptides (≤35 residues). 
2.2. Methodologies 
The strategy applied for both the literature and protein databases searches described in this report 
followed three key principles:  
1. methodological rigour and coherence in the retrieval and selection of studies;  
2. reproducibility; 
3. transparency. 
To ensure that these principles were implemented in the searches, the methods and techniques 
described in the EFSA guidance on application of systematic review methodology to food and feed safety 
assessments to support decision-making (EFSA, 2010) were applied. The most up-to-date searches 
were conducted in March 2020. 
Section 2.2.1 describes the key steps of the search strategy to identify toxic proteins to populate both 
the Main and TAS collections. For these proteins a Python script was produced to automatically download 
all the available structures and models, to collect all the respective UniProtKB-based information and to 
cluster the identified proteins. This Python script together with the associated user guide and an 
illustrative video are provided to EFSA as an Annex to the final report. 
Section 2.2.2 describes the approach to the search for proteins with putative toxic activity as aggregates. 
This differs from the previous searches, since aggregation-prone proteins cannot be classified as toxins 
per se based on scientific evidence; moreover, no 3D structures were collected for these entries.  
For both approaches, the starting point was a UniProtKB search; the search terms were defined based 
on the GO database terminology and subsequently refined (see details below). Three different literature-
containing databases were queried to retrieve relevant information (Table 1).  
All the related information from UniProtKB (e.g. keywords, GOs, primary structure-related information, 
organism of origin) was extracted and stored in separate lists (the respective Excel tables containing 
these lists supplement this report). 
2.2.1. Compilation of a comprehensive collection of information 
for toxic proteins 
Six steps were undertaken to compile a comprehensive collection of information on toxic proteins (Figure 
6). 
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Figure 6: Schematic representation of the comprehensive protein toxin search. 
These steps included a primary search to identify toxic proteins in UniprotKB (Step 1) and in literature 
databases (Step 2); a secondary search expanding on toxin-antitoxin systems in UniprotKB (Step 3); a 
consistency check between the papers identified in the above searches and those from literature 
databases, using the same keywords (Step 4); a robustness check testing different search terms (step 
5); and finally data extrapolation and clustering (Step 6). A detailed description of Steps 1-6 is provided 
below. 
Step 1: Searches in UniProt database 
Strategy: To answer the question “Which proteins are associated with a well-recognised toxic activity 
(i.e. cause toxic effects per se?”, we made reference to the term “toxin activity” found in GO: proteins 
showing toxin activity are those that interact selectively with one or more biological molecules in another 
organism (the "target" organism), initiating pathogenesis (leading to an abnormal, generally detrimental 
state) in the target organism. The activity should refer to an evolved function of the active gene product, 
i.e. one that was selected for. The main search for toxic proteins was carried out querying the UniProtKB 
database. Papers linked to the retrieved Uniprot entries were selected as relevant literature and included 
in the Main Collection. Full details of the search are reported in Box 1 below. 
Box 1 
Question Which proteins are associated with a well-recognized toxic activity (i.e. cause toxic 
effects per se)? 
Keyword 
 
To select relevant studies concerning proteins with associated toxic activity per se 
from the comprehensive set of literature previously compiled the following 
keywords were used in the UniProtKB search:  
“Toxin activity and Reviewed:Yes” and “Toxin activity and Reviewed:No” 
Rationale 
The search strategy was based on the term “Toxin activity” described in GO 
Annotation database (Table 6), since this term was as the most relevant term to 
address the terms of reference of this work. This term was used as the UniProtKB 
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 search term, as mentioned above. The full definition of this term as provided by the 
GO is reported in the table below.  
Table 6: “Toxin activity” term in Gene Ontology   
Term:  Toxin activity 
Synonyms:  toxin receptor binding 
Definition:  Interacting selectively with one or more biological molecules in another organism (the 'target' 
organism), initiating pathogenesis (leading to an abnormal, generally detrimental state) in the 
target organism. The activity should refer to an evolved function of the active gene product, 
i.e. one that was selected for. Examples include the activity of botulinum toxin, and snake 
venom. 
Parent terms:  is-a molecular function 
Category:  Molecular Function 
Id:  GO:0090729 
Results: The proteins identified from “Toxin activity and Reviewed:Yes” string search constitute the Main 
Collection (Table 7). As expected, the GO “toxin activity” term was present in each entry and was used 
as the main term for the Main Collection search. For the Main Collection we selected only the annotated 
proteins (Annex A), with the associated literature already revised by UniProtKB curators.  Non-annotated 
protein entries and associated literature were stored into a separate database (Annex B). We do not 
consider the non-annotated proteins as part of the Main Collection. With this strategy we extended the 
collection of protein toxins already identified in the UniprotKB “Toxin annotation project” for toxins of 
animal origin to also include bacterial and plant toxins while verifying at the same time that all the 
animal toxins annotated within the UniprotKB project were included in the Main Collection. 
Table 7: Number of selected toxins for Main Collection (March 2020) 
UniProt string Reviewed:YES Reviewed:NO 
“Toxin activity” 6,964 47,831 
Step 2: Literature database search 
Literature sources (Scopus, Web of Science and PubMed) were also queried using the “toxin activity” as 
the search term, with the aim of verifying that all the papers selected from Step 1 are also retrievable 
in these literature databases. For each entry, the article DOI (Digital Object Identifier) was used as the 
unique identifier and authors, title, journal and source were also considered. Table 7 lists the number 
of papers found for each search string using PubMed, Web of Science and Scopus, respectively. Results 
are reported in Table 8. The identified papers were then cross-checked (please, see the Step 4). 
Table 8: Papers in the three source literature databases for the Main Collection 
String search PubMed WOS SCOPUS 
“Toxin activity” 570 529 709 
toxin activity 77,726 34,935 50,214 
Step 3: Citation pearl growing strategy using publications known to be landmark 
publications in the field  
Strategy: Using a pearl growing strategy we extended our search to proteins relevant in the context of 
this work but not associated to the GO term ‘toxic activity’. From the publications in the Main Collection, 
50 highly representative papers, considered as landmark publications in the field based on both citations 
and number of toxins discussed, were selected and reviewed (Table 9). The selection of the papers was 
based on the number of toxins cited (avoiding repetition of organism of origin or specific protein), and 
the presence of a description of toxic effects/pathways. Among these, five papers concerning 
Mycobacterium tuberculosis and Escherichia coli were included since these bacteria resulted associated 
with the highest number of bacterial toxic proteins (see the “Organism” Excel file of the TAS Collection 
for details on the toxins from these bacteria). Based on these papers, a new keyword was identified as 
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relevant (see Box 2 and Table 10) and an additional search was run in the UniProtKB database, giving 
rise to the TAS Collection. The new search covers additional bacterial toxins, that are not 
comprehensively present in the Main Collection. Cold shock-like protein CspD from E.coli and 
Ribonuclease VapC2 from M. tuberculosis are the only two proteins to have associated both GO terms 
“Toxin activity” and “Toxin-antitoxin” system. 
Box 2 
Question 
 
How to extend the toxic protein Main Collection with UniProtKB annotated proteins 
taking into account the outcome of the primary search (identification of a new 
search term)? 
Keywords In order to select relevant studies concerning proteins with some associated toxic 
effect but not covered by the GO term toxin activity, the following keywords were 
used: 
“Toxin-antitoxin system and Reviewed:Yes” and “Toxin-antitoxin system and 
Reviewed:No”.  
Rationale 
Some proteins identified through the primary search were noted to belong to a 
toxin-antitoxin system (TAS); however it was observed that not all of these TAS 
proteins were associated with the GO term “Toxin activity” in the UniProtKB 
database but they were linked to toxin activity in the peer-reviewed literature. In 
fact, the term “toxin activity” in UniProtKB refers to proteins that have a well-
recognized toxic activity per se, and that interact primarily with proteins of the 
target organism. Toxins that belong to TAS primarily interact with their antitoxins 
and are able to interact with proteins of a target organism only if the toxin-antitoxin 
equilibrium is disrupted. Based on the above observations, a pearl growing strategy 
was applied to identify these additional TAS toxins. 
 
Table 9: List of the 50 selected papers. 
UniProt Pubmed ID Title 
P0C1N6 11158371 Mechanisms for evolving hypervariability: the case of conopeptides. 
P59939 12459475 
A large number of novel Erg toxin-like genes and ERG K+-channels blocking 
peptides from scorpions of the genus Centruroides. 
P60210 15025998 
Proteomics of the venom from the Amazonian scorpion Tityus cambridgei 
and the role of prolines on mass spectrometry analysis of toxins. 
P0DJM6 15032748 
Molecular evolution and structure-function relationships of crotoxin-like and 
asparagine-6-containing phospholipases A2 in pit viper venoms. 
P0CF14 15688451 A novel strategy for the identification of toxin-like structures in spider venom. 
A8S6B3 16261251 
Identification and analysis of venom gland-specific genes from the coastal 
taipan (Oxyuranus scutellatus) and related species. 
O76199 16278100 
Comparison of the partial proteomes of the venoms of Brazilian spiders of 
the genus Phoneutria. 
Q09GJ9 16292255 Early evolution of the venom system in lizards and snakes. 
P0CI13 16477526 
Genes expressed in a turrid venom duct: divergence and similarity to 
conotoxins. 
Q1A3Q1 16908117 
Diversity and evolution of conotoxins based on gene expression profiling of 
Conus litteratus. 
P0C8B6 17320133 
Venomic analyses of Scolopendra viridicornis nigra and Scolopendra angulata 
(Centipede, Scolopendromorpha): shedding light on venoms from a 
neglected group. 
A0SE59 17400270 
From the identification of gene organization of alpha conotoxins to the 
cloning of novel toxins. 
B1P1A4 17476710 
Proteomic and peptidomic analysis of the venom from Chinese tarantula 
Chilobrachys jingzhao. 
A7X3M3 17855442 
Evolution of an arsenal: structural and functional diversification of the venom 
system in the advanced snakes (Caenophidia). 
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A7SCE5 18222944 
Concerted evolution of sea anemone neurotoxin genes is revealed through 
analysis of the Nematostella vectensis genome. 
B1P1A0 18581053 
Molecular diversity and evolution of cystine knot toxins of the tarantula 
Chilobrachys jingzhao. 
B2ZBB8 18923708 
Discovery of a distinct superfamily of Kunitz-type toxin (KTT) from 
tarantulas. 
C0JAQ5 19042943 
Molecular evolution, functional variation, and proposed nomenclature of the 
gene family that includes sphingomyelinase D in sicariid spider venoms. 
B4XSY4 19059426 
C-type lectin protein isoforms of Macrovipera lebetina: cDNA cloning and 
genetic diversity. 
B9W5G6 19268680 Molecular mechanism of pore formation by actinoporins. 
P00624 19371136 
Exploring the venom proteome of the western diamondback rattlesnake, 
Crotalus atrox, via snake venomics and combinatorial peptide ligand library 
approaches. 
P0C1N6 19380747 Rapid sensitive analysis of cysteine rich peptide venom components. 
P0DL61 19627569 
Comprehensive EST analysis of the symbiotic sea anemone, Anemonia 
viridis. 
B6DCJ0 19875276 
Transcriptome analysis of the venom glands of the Chinese wolf spider 
Lycosa singoriensis. 
D2Y1X6 20192277 
Molecular diversification of peptide toxins from the tarantula Haplopelma 
hainanum (Ornithoctonus hainana) venom based on transcriptomic, 
peptidomic, and genomic analyses. 
A6YR40 20363338 
Evolution of Conus peptide toxins: analysis of Conus californicus Reeve, 
1844. 
C6ZH27 20663230 
Comparative venom gland transcriptome analysis of the scorpion Lychas 
mucronatus reveals intraspecific toxic gene diversity and new venomous 
components. 
D2Y100 21172372 
Diversity of conotoxin types from Conus californicus reflects a diversity of 
prey types and a novel evolutionary history. 
C1J5M6 21266071 
Characterization of the Conus bullatus genome and its venom-duct 
transcriptome. 
P0DMX6 21281459 
The mining of toxin-like polypeptides from EST database by single residue 
distribution analysis. 
C6JUP1 21515432 
Snake venomics and venom gland transcriptomic analysis of Brazilian coral 
snakes, Micrurus altirostris and M. corallinus. 
C9X4J8 22355312 
Identification and phylogenetic analysis of Tityus pachyurus and Tityus 
obscurus novel putative Na+-channel scorpion toxins. 
I6R1R5 22595790 Chemical punch packed in venoms makes centipedes excellent predators. 
B3EWS5 22672445 
Multicomponent venom of the spider Cupiennius salei: a bioanalytical 
investigation applying different strategies. 
A7LCJ2 22683676 
Development of a rational nomenclature for naming peptide and protein 
toxins from sea anemones. 
P0C1N6 22709442 Constrained de novo sequencing of conotoxins. 
P01022 22869554 
Peptidomics of three Bothrops snake venoms: insights into the molecular 
diversification of proteomes and peptidomes. 
A0A0R4I951 23148443 
Venomic and transcriptomic analysis of centipede Scolopendra subspinipes 
dehaani. 
F8S0Y4 24231107 
Linking the transcriptome and proteome to characterize the venom of the 
eastern diamondback rattlesnake (Crotalus adamanteus). 
A3R0T9 24297900 
The king cobra genome reveals dynamic gene evolution and adaptation in 
the snake venom system. 
W4VRU3 24351713 
A proteomics and transcriptomics investigation of the venom from the 
barychelid spider Trittame loki (brush-foot trapdoor). 
A0A023IWD9 24613547 The molecular diversity of toxin gene families in lethal Amanita mushrooms. 
A0A023VZR2 24847043 
Clawing through evolution: toxin diversification and convergence in the 
ancient lineage Chilopoda (centipedes). 
P0DN44 26025559 
Molecular diversity and gene evolution of the venom arsenal of Terebridae 
predatory marine snails. 
B3EWF2 27287558 Lachesana tarabaevi, an expert in membrane-active toxins. 
Literature search – Exploring in silico protein toxicity prediction methods to support food/feed RA 
 
 
 
www.efsa.europa.eu/publications 21 EFSA Supporting publication 2020: EN-1875 
The present document has been produced and adopted by the bodies identified above as authors. This task has been carried out exclusively by the authors 
in the context of a contract between the European Food Safety Authority and the authors, awarded following a tender procedure. The present document 
is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. 
The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present 
document, without prejudice to the rights of the authors). 
 
 
P9WFB9 15718296 
Toxin-antitoxin loci are highly abundant in free-living but lost from host-
associated prokaryotes. 
P69348 19028895 
Influence of operator site geometry on transcriptional control by the YefM-
YoeB toxin-antitoxin complex 
Q47149 17263853 Escherichia coli dinJ-yafQ genes act as a toxin-antitoxin module 
O07227 20011113 
Comprehensive functional analysis of Mycobacterium tuberculosis toxin-
antitoxin systems: implications for pathogenesis, stress responses, and 
evolution. 
Q47150 19707553 
A differential effect of E. coli toxin-antitoxin systems on cell death in liquid 
media and biofilm formation. 
 
Table 10: Definition of toxin-antitoxin systems (Unterholzner et al., 2013) 
Term:  Toxin-antitoxin systems (TAS) 
Definition:  TAS were defined as follows (Unterholzner et al., 2013): “TAS are small genetic elements 
composed of a toxin gene and its cognate antitoxin. The toxins of all known TAS are proteins 
while the antitoxins are either proteins or non-coding RNAs. Based on the molecular nature 
of the antitoxin and its mode of interaction with the toxin, the TAS modules are currently 
grouped into six classes. In general, the toxin is more stable than the antitoxin but the latter 
is expressed to a higher level. If supply of the antitoxin stops, for instance under special 
growth conditions or by plasmid loss in case of plasmid-encoded TAS, the antitoxin is rapidly 
degraded and can no longer counteract the toxin. Consequently, the toxin becomes activated 
and can act on its cellular targets. Typically, TAS toxins act on crucial cellular processes 
including translation, replication, cytoskeleton formation, membrane integrity, and cell wall 
biosynthesis. TAS and their components are also versatile tools for a multitude of purposes 
in basic research and biotechnology. Currently, TAS are frequently used for selection in 
cloning and for single protein expression in living bacterial cells. Since several TAS toxins 
exhibit activity in yeast and mammalian cells they may be useful for applications in eukaryotic 
systems. TAS modules are also considered as promising targets for the development of 
antibacterial drugs and their potential to combat viral infection may aid in controlling 
infectious diseases.”  
Results: To populate the TAS Collection we selected only the annotated proteins reviewed by UniProtKB 
curators (Annex C), while non-annotated proteins and associated literature were stored into a separate 
database (Annex D). Unreviewed proteins are not part of the TAS Collection. Following the Step 2 
procedure, we queried the literature sources (Scopus, Web of Science and PubMed) using the “toxin-
antitoxin system” as the search term. Table 11 lists the number of selected toxins from UniProtKB that 
populated the TAS Collection, while Table 12 lists the number of papers found for each search string 
using PubMed, Web of Science and Scopus, respectively.  
Table 11: Number of selected toxins for TAS Collection (March 2020) 
Search string Reviewed: Yes Reviewed: No 
Toxin-Antitoxin System 627 155,039 
 
Table 12: Papers in the three source literature databases for the TAS Collection 
String search PubMed WOS SCOPUS 
“Toxin-antitoxin system” 365 420 776 
Toxin-antitoxin system 1,169 1,260 1,060 
Step 4: Literature search consistency 
In order to cross-check literature information identified through the UniProtKB and literature database 
(PubMed, WOS and Scopus) searches for both Main and TAS Collections, we verified that all the papers 
found from the UniProtKB searches (Step 1 & 3) could also be found in either PubMed, WOS or Scopus 
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searches (Step 2 & 3). Table 13 reports the number of selected papers associated to each collection. 
Duplicate papers were removed. 
Table 13: Number of selected papers (March 2020) 
Search string Reviewed: Yes Reviewed: No Collection 
“Toxin activity” 5430 2143 Main 
“Toxin-AntiToxin 
System” 
482 1970 TAS 
Step 5: Exclusion of other search terms 
We also verified the robustness of the selected search strings (Step 1 and Step 2) in covering all the 
proteins marked as toxic in the UniProtKB database, confirming that by using different word 
combinations (e.g. toxic and proteins, toxic and animals, toxic and enzymes) searching UniProtKB it 
would not result in the identification of additional proteins classifiable as toxins, as shown in Table 14. 
Table 14: Exclusion of search terms evaluation 
Search string Findings 
“Toxic” and its 
combination with 
other words 
Using this string leads to the retrieval of toxic proteins per se, which are included in 
‘Toxin Activity’; and proteins not relevant to the scope of the search e.g. Q9LPV4 – 
Protein detoxification 31(DTX31_ARATH) 
“Toxicity” and its 
combination with 
other word 
Proteins with associated toxicity are included in ‘Toxin Activity’, but some of them are 
not related with the aim of the search e.g. P33302 - Pleiotropic ABC efflux transporter 
of multiple drugs (PDR5_YEAST) 
“Pathogen” and its 
combination with 
other word 
Proteins with associated toxicity are included in ‘Toxin Activity’, but some of them are 
not related with the aim of the search e.g Q94C26 - Cysteine-rich and transmembrane 
domain-containing protein PCC1 (PCC1_ARATH) 
“Toxin” It includes Toxin Activity, Toxin-antitoxin but also some other proteins that are not 
toxic per se e.g. O00476 - Sodium-dependent phosphate transport protein 4 
(SLC17A3), associated with the toxin transmembrane transporter activity (GO: 
0019534) 
Step 6: Data extrapolation and clusters 
Information from UniProtKB for both Collections (Main and TAS) was stored into different Excel files, for 
possible further analyses (see Table 15). The proteins in these collections were clustered based on the 
annotated UniprotKB flags. 
Three different flags were used to group the proteins:  
- Keyword, that contains all the UniProt-related keywords; 
- GO, that contains all the GO-related labels; and 
- Organism, that contains all the organisms that express the selected proteins. 
Table 15 lists the Excel files and Annexes delivered with this Final Report as part of results. 
Table 15: Files and Annexes delivered with the Report 
Collection File3/Annex Contents 
Main Collection MC_citation_scopes.xlsx Citations with statistics of UniProtKB scopes 
Main Collection MC_citations.xlsx Citations 
Main Collection MC_comments.xlsx UniProtKB comments 
Main Collection MC_databases.xlsx 
Families, domains and signatures classification according to 
databases 
Main Collection MC_go.xlsx GO terms 
Main Collection MC_keywords.xlsx UniProtKB keywords 
                                                 
3 Supplementary files in Folder#1 
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Main Collection MC_organisms.xlsx Organisms from UniProtKb 
Main Collection MC_pdb.xlsx 
Available experimentally solved structures (from RCSB Protein 
Data Bank) 
Main Collection MC_Pfam_identities.xlsx Identities in databases with respect to Pfam 
Main Collection MC_sequences.xlsx Toxin sequences 
Main Collection MC_swiss_models.xlsx Models from the Swiss Model Repository 
TAS Collection TC_citation_scopes.xlsx Citations with statistics of UniProtKB scopes 
TAS Collection TC_citations.xlsx Citations 
TAS Collection TC_comments.xlsx UniProtKB comments 
TAS Collection TC_databases.xlsx 
Families, domains and signatures classification according to 
databases 
TAS Collection TC_go.xlsx GO terms 
TAS Collection TC_keywords.xlsx UniProtKB keywords 
TAS Collection TC_organisms.xlsx Organisms from UniProtKb 
TAS Collection TC_pdb.xlsx 
Available experimentally solved structures (from RCSB Protein 
Data Bank) 
TAS Collection TC_Pfam_identities.xlsx Identities in databases with respect to Pfam 
TAS Collection TC_sequences.xlsx Toxin sequences 
TAS Collection TC_swiss_models.xlsx Models from the Swiss Model Repository 
TAS Collection TC_citation_scopes.xlsx Citations with statistics of UniProtKB scopes 
Main Collection Annex A Results for Toxin Activity, Reviewed:YES 
 Annex B Results for Toxin Activity, Reviewed:NO 
TAS Collection Annex C Toxin-antitoxin system, Reviewed:YES 
 Annex D Toxin-antitoxin system, Reviewed:NO 
Main and TAS 
Collections Annex E Pfam results 
Main and TAS 
Collections Annex F Interpro results 
2.2.2. Proteins with putative toxic activity as aggregates 
This section illustrates the search strategy that has been introduced in this project to expand the scope 
of Task 1, in order to also investigate proteins that may misfold and/or polymerize under specific 
circumstances (”aggregates”) causing pathological effects, as requested by EFSA and specified in section 
1.2. These proteins are physiological components of the organism and do not fit with the definition in 
the GO “toxin activity” (see Table 6), since they act in the same organisms that express them. 
Consistently with these observations, none of the protein aggregates was retrieved with the searches 
carried out during the previous steps of this work. Accordingly, a dedicated search strategy was set up 
(Figure 7). 
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Figure 7: Schematic representation of the aggregates search. 
A preliminary search in PubMed using the search string “protein toxicity” yielded a little more than 150 
papers (full details are not reported in this report). Browsing the retrieved items it was noted that in 
scientific literature the term ‘protein toxicity’ is used not only to describe, in its proper sense, the noxious 
effects of exogenous proteins – toxin and TAS dealt with in the previous sections of this report – but 
also, arguably stretching the meaning of the term, to include the noxious effects of some endogenous 
proteins. Indeed, a few proteins – non-toxic per se but rather involved in some essential physiological 
function(s) in humans/animals – may become misfolded and/or aggregated under specific 
circumstances, with negative effects that appear to exceed the expected loss-of-function.  
Details on the strategy followed are presented in Box 3. 
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Box 3 
Question Which proteins form in vivo aggregates connected with human or animal pathology? 
Keywords 
 
The keywords used for search in UniProt were amyloidosis and aggregat* (to 
include both aggregate and aggregation); the latter was used twice, first limiting 
the search to human proteins, then to non-human proteins.  
Rationale 
 
Scientific reports retrieved in literature databanks with the search term ‘toxic 
protein’ identify the insoluble deposits connected with human pathology, in most 
cases, with structured protein aggregates, formed in a process defined amyloidosis; 
in other cases, with unstructured aggregates.  
 
Results: The 50 most cited papers for each query in the bibliographical databases were carefully 
evaluated to understand if protein aggregation could be considered as a toxic pathway and proteins 
involved in this pathological mechanism could be classified as toxins. Tables 16 and 17 summarize the 
results. As a result, we also found that the word “toxic” is improperly used in the literature to describe 
the effects of protein aggregates since none of these proteins have associated the “toxin” label in 
UniProtKB. 
Table 16: Search terms statistics in bibliographic databases 
Search string PubMed Scopus Web of Science 
“amyloidosis” 31,053 39,517 25,668 
"protein 
aggregation" OR 
"protein aggregate" 
83,328 40,198 
 
11,312 
Table 17: Results of aggregates-related searches  
Search Findings 
Amyloidosis In PubMed, the query « “amyloidosis” » retrieved little more than 30,000 papers, including 
little less than 5,000 reviews, defining it as the most specific and at the same time the furthest 
reaching search term to retrieve aggregation-prone molecules from the literature. Since the 
other two sources, i.e. Scopus and Web of Science, produced the same results, PubMed was 
selected as the reference source of information. We searched the UniProt database with the 
string: amyloidosis AND reviewed:yes, and retrieved 71 entries; we reviewed the list by 
inspecting the content of each entry. 
Amyloidosis is not associable to toxins. 
Protein 
aggregates 
To consider the situations in which proteins may assemble in a disordered/less-organised form 
than amyloid fibers, an additional search was conducted. The search string « "protein 
aggregation" OR "protein aggregate" » in PubMed yielded over 80,000 entries. The other two 
sources, i.e. Scopus and Web of Science, produced the same results. 
Protein aggregates are not associable to toxins. 
Aggregation 
of human 
proteins 
We thus set a search with main keyword ‘aggregat*’ to include both aggregate (noun and 
verb) and aggregation. As we did not want to duplicate findings, we included in the search 
string the words ‘NOT amyloidosis’ in order to disregard all proteins already identified by the 
‘aggregation search’; the difference in number, however, was negligible. As we meant to 
monitor first proteins relevant to human pathologies, and on the basis of the results of the 
previous search for amyloidosis, we initially restricted the search to our species by including in 
the search string the words AND organism:"Homo sapiens (Human) [9606]". Accordingly, the 
search string for our second interrogation of UniProt for endogenous proteins run as: « 
aggregat* NOT platelet NOT amyloidosis AND reviewed:yes AND organism:"Homo sapiens 
(Human) [9606]" ». Same as for above, the results of the search were manually inspected. 
Aggregation of human proteins is not associable to toxins. 
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Aggregation 
of animal 
proteins 
While the overall scenario was already clear, we repeated anyhow the search excluding human 
proteins by using the search string « aggregat* NOT platelet NOT amyloidosis NOT human 
AND reviewed:yes » in UniProt. We then individually inspected the over 3,500 entries to include 
only animals, ending up with a selection of 548 items. 
Aggregation of animal proteins is not associable to toxins. 
2.3. Three-dimensional structures 
The RCSB Protein Data Bank (PDB) was queried to retrieve all the related experimentally-determined 
structures to integrate the entries in both the Main and the TAS collections. The experimentally-
determined structure selected for each protein was based on both primary structure coverage and 
experimental resolution (weighing these two terms 80% and 20%, respectively). All the selected 
structures were structurally-refined and energy-minimised using, respectively, the MOE software and 
Amber10:ETH as forcefield. Gaps in the secondary structures were filled through the ‘loop modelling’ 
procedure in which structure-related errors were also fixed, hydrogens were added while water and 
hetero-molecules were removed. By these steps, we refined the 3D structures retrieved from the PDB, 
generating an energy-minimized state for each structure. 
The Swiss-model (SM) repository was queried to collect all the available 3D predicted models of proteins 
for which no experimentally-determined structure was available. Proteins found neither in PDB nor in 
the SM repository and with primary structure longer than 30 amino acids were modelled by us using 
the SM modelling tool; 30 amino acids is the lower limit for modelling in SM. For each SM-generated 
model, two different parameters (GMQE and QMEAN, Benkert et al., 2011) were carefully assessed in 
order to verify the quality of the structure. GMQE (Global Model Quality Estimation) is a quality 
estimation that combines properties from the target–template alignment and the template search 
method. The resulting GMQE score is expressed as a number between 0 and 1, reflecting the expected 
accuracy of the built model. The closer the GMQE score is to 1, the higher the reliability. On the other 
hand, QMEAN is a composite estimator based on different geometrical properties and provides both 
global (i.e. for the entire structure) and local (i.e. per residue) absolute quality estimates on the basis 
of one single model (Benkert et al., 2011). 
Using CPH model, we also generated 3D models for peptides with primary structure between 20 and 30 
amino acids, while peptides shorter than 20 amino acids were not modelled, since the accuracy is 
expected to be low due to the intrinsic disorder in the folding of very short sequences (Ohtake et al., 
2013).  
Consistently with the experimentally-determined 3D structures, all the SM and CPH protein/peptide 
models were also structure-prepared and energy-minimized using MOE software and Amber10:ETH as 
forcefield. 
2.4. Families, domains and signatures 
Redundancy among sources was investigated leading us to conclude that Pfam can be considered the 
main reference source for protein family classification, while InterPro can be considered the most 
complete database for both domains and signatures clustering. Although these two databases are 
interconnected, they provide the users with different classifications of the proteins, useful to perform 
different kinds of analysis or search. For this reason, the two databases cannot be considered equivalent. 
For each family in Pfam and domain/signature in Interpro, a brief description is reported in the Results 
section (Section 3), while the comprehensive results are listed in Annex E and Annex F, respectively. 
Moreover, a reference protein was selected, on the basis of the root mean square deviation (RMSD) of 
the positions of its αlpha-carbons vs the protein family, and carefully checked, reporting in the Results 
section all the associated domains found in order to have a reference structure of the family, like a 
centroid of a cluster. 
2.5. Automated information retrieval and management tool 
A Python-based automated tool (script) was created in order to retrieve and manage all the information 
on the identified toxic proteins and associated literature. This tool queries the UniProtKB database and 
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interprets the .xml response by building an object-oriented Python-based database. From this object-
oriented database many Excel-compatible tables are generated reporting and summarizing all the 
entries retrieved by the query. For each retrieved UniProtKB entry, a folder is created and filled with the 
sequence, the structure and other relevant information. For each entry the best structure is obtained 
first by trying to download the PDB structure, then, if none is available, by attempting to download the 
best SM model for the sequence; it is however also possible to add a user-made model. After these 
steps, the available structures are refined by automatically calling the external program MOE and by 
applying a standard protocol for processing. MOE is not included into the automated tool that is provided 
to EFSA, so the refinement option is not available. 
3. Results 
The searches conducted in this work according to the methodology described in Section 2 resulted in 
the definition of: 
 two exhaustive collections of information on toxic proteins, based on UniProtKB database: the 
Main collection, containing information on proteins toxic per se; and the TAS collection, 
informing on proteins belonging to toxin-antitoxin systems (TAS). All the information retrieved 
on the identified toxic proteins and associated literature are managed by an ad hoc Python-
based software. The results are presented in detail in Section 3.1; 
 a compilation of information on protein aggregates associated with pathological conditions, 
with results discussed separately in Section 3.2.  
The in silico pipeline developed to support the search is summarised in Figure 8. Furthermore, the 
results of the quality assurance of 3D structures of toxic proteins and of the testing of the main freely 
available on-line tools for predicting protein toxicity are presented in Section 4 and 5 respectively.  
This report provides information on all toxic proteins currently known based on the available information 
and the state-of-the-art of scientific research in this field. It cannot be excluded that some additional 
toxic proteins not yet characterised as toxins do exist.  
 
Figure 8: In silico pipeline devised to fulfil the EFSA request. 
3.1. Toxic proteins 
This report is structured in order to provide information on 1) the number of proteins fitting the definition 
of proteins causing toxic effects per se or belonging to TAS, respectively; 2) the primary structure length 
of these proteins (expressed as distributions); 3) the organisms that produce them, 4) the associated 
GO terms (Molecular Function, Cellular Component and Biological Process) and 5) keywords. 
The proposed structure has been chosen since matching the gold standard database UniProtKB (and 
related databases). This can facilitate possible further bioinformatics analysis in this area. Further 
detailed information on the toxicity of each identified protein is reported in Annexes A-D, as detailed in 
the sections below.  
3.1.1. Main Collection 
As detailed in Section 2.2.1, proteins causing toxic effects per se are identified in UniProtKB by the 
keyword “toxin activity”. Full details are reported in the Main Collection related annexes (see Table 15). 
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3.1.1.1. Number of proteins identified  
Data on 6,964 proteins with an associated well-recognised toxic activity (i.e. causing toxic effects per 
se, Keyword “Toxin activity and Reviewed:Yes”) were downloaded from UniProtKB (March 2020). Among 
them, 4,225 have a precursor sequence (i.e. a sequence containing a peptide that inhibits the toxic 
function until it is removed), while 1,157 are labelled as fragments (the whole primary structure is still 
unknown). Full details are included in Excel files (see Table 15); an example is presented in Table 18.  
Table 18: Example of primary structures table (see MC_sequences.xlsx) 
 
Fragment: is used to inform that the protein is only a fragment of the primary sequence  
Precursor: informs if the toxin has a precursor 
Structure: source of download for the selected structure  
Length: number of amino acids in the primary structure  
Experimental determination of the structure: informs on the percentage of the primary structure coverage of the experimentally-
derived 3D model (with respect to the entire length of primary structure)  
Best pdb: the protein data bank code of the best resolved 3D structure  
3.1.1.2. Sequence length 
As shown in Figures 9 and 10, ~ 90% of the proteins are shorter than 300 amino acids whereas ~65% 
are shorter than 100 amino acids. Only 465 proteins (~7%) are shorter than 20 amino acids and were 
not modelled. 
Figure 9: Histogram of the primary structure length for proteins causing toxicity per se  - Main Collection 
(up to 300 amino acids in length).  
 
Uniprot Fragment Precursor Structure Length Experimental 
determination of 
the structure 
Best pdb 
P62377   Swiss Model 62 0  
P25681   Swiss Model 61 0  
P0CG02   Swiss Model 60 0  
Q98962  true Swiss Model 81 0  
Q9W716  true Swiss Model 83 0  
Q53B57  true Swiss Model 91 0  
B2KKV7 single true Swiss Model 302 0  
P01452   PDB 60 100% 1cdt 
… … … … … … … 
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Figure 10: Histogram of the primary structure length proteins causing toxicity per se. 
3.1.1.3. Organisms 
Reviewing the information on the organisms that express the selected toxins, we found that the most 
representative ones (i.e. those expressing the highest number of toxins) belong to the animal kingdom. 
The most recurrent organism is Cyriopagopus hainanus (292 proteins), followed by Lycosa singoriensis 
(217 proteins), Californiconus californicus (118 proteins), Chilobrachys guangxiensis (104 proteins) and 
Conus textile (100 proteins). In the following lines, a brief description is reported for the five most 
representative organisms: 
i) Cyriopagopus hainanus is a spider species from the family Theraphosidae (tarantulas), 
found in China; it is also known as the "Chinese bird spider". Its venom contains different 
proteins (e.g. hainantoxins) able to inhibit tetrodotoxin-sensitive voltage-gated sodium 
chanels, causing blockage of neuromuscular transmission; 
ii) Lycosa singoriensis is a hunting spider with a widespread distribution in Northwest China. 
The venom gland of these spiders can secrete abundant and complex neurotoxins;  
iii) Californiconus californicus, common name the Californian cone, is a species of small, 
predatory sea snail, a marine gastropod mollusc in the family Conidae, the cone snails, 
secreting a conotoxin; 
iv) Chilobrachys guangxiensis is a species of Araneae in the family Theraphosidae, found in 
China; it is also known as the "Chinese fawn tarantula"; it secretes proteins inhibiting 
voltage-gated potassium channels; 
v) Conus textile Linnaeus is a marine gastropod mollusc of the Conidae family, widespread in 
the Red Sea and in the coral reefs of South-east Asia and Australia. Its poison, containing 
neurotoxins belonging to the family of the counterfeiters, is dangerous and often even 
deadly for humans. 
The five most representative organisms from Bacteria, Plantae and Fungi kingdoms are also highlighted: 
Bacteria: 
i) Bacillus thuringiensis is a Gram-positive, soil-dwelling bacterium, commonly used as a 
pesticide. It also occurs naturally in the gut of caterpillars of various types of moths and 
butterflies, as well on aquatic environments, leaf surfaces, insect-rich environments, animal 
faeces and grain-storage facilities. During sporulation, it produces crystal proteins (Cry 
proteins), among which there are δ-endotoxins that promote colloidosmotic lysis by binding 
to the midgut epithelial cells of many lepidopteran larvae; 
ii) Escherichia coli is the most widely studied prokaryotic model organism, and an important 
species in the fields of biotechnology and microbiology, where it has served as the host 
organism for the majority of work with recombinant DNA. It expresses hemolysin, which 
has some hemolytic activity towards mammalian cells; 
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iii) Mannheimia haemolytica is an opportunistic bacterium able to gain access to the lungs 
when the host defences are compromised by infection due to respiratory viruses or 
mycoplasma, such as parainfluenza, IBR or environmental stress. It expresses leukotoxins, 
exotoxins that attack host leukocytes and especially polymorphonuclear cells, causing cell 
rupture; 
iv) Staphylococcus aureus is a facultative anaerobe, Gram-positive bacterium and a usual 
member of the microbiota of the body: it can be found on human skin, nose, armpit, groin, 
and other areas. Staphylococcal enterotoxins cause the intoxication staphylococcal food 
poisoning syndrome. In particular S. aureus expresses beta-hemolysin, a phospholipase C 
with specific activity toward sphingomyelins; 
v) Streptococcus pyogenes is a Gram-positive and catalase-negative bacterium that causes 
several diseases in human beings such as pharyngitis, skin and throat infections and acute 
rheumatic fever. It expresses streptolysin, a sulfhydryl-activated toxin that causes cytolysis 
by forming pores in cholesterol-containing host membranes. It is commonly used in 
bionanotechnology and genome editing, such as CRISPR. 
Plantae: 
i) Abrus precatorius, commonly known as jequirity bean or rosary pea, is a weedy and invasive 
plant typical of temperate and tropical regions, such as Asia and Australia, which contains 
one of the most lethal toxins, abrin, a toxalbumin that inhibits protein synthesis, causing 
cell death; 
ii) Arabidopsis thaliana is a small, diploid and short-lived flowering plant native to Eurasia and 
Africa, member of the mustard family (Brassicaceae), including cultivated species such as 
cabbage and radish, which is a powerful model for the study of growth and development 
processes in plants, due to its relatively small genome of approximately 135 megabase pairs 
and 5 chromosomes. A. thaliana expresses thionins, small plant proteins that are toxic to 
animal cells. They seem to exert their toxic effect at the level of the cell membrane; 
iii) Hordeum vulgare (barley) is a diploid photoautotroph herbaceous species of plant of the 
family of True grasses, with 14 chromosomes and a self-supporting growth habit. It’s a 
major cereal grain with simple, broad leaves and yellow flowers. Barley has been largely 
used as animal fodder, as a source of fermentable material for beer and certain distilled 
beverages, and as a component of various foods. It expresses thionins that are small plant 
proteins toxic to animal cells. They seem to exert their toxic effect at the level of the cell 
membrane. 
Fungi: 
i) Amanita bisporigera is a deadly poisonous fungus from the family of the Amanitaceae. The 
mushroom has a smooth white cap, which can reach up to 10 cm in diameter, and a stipe, 
up to 14 cm long. It contains amatoxins, cyclic peptides that inhibit the enzyme RNA 
polymerase II and interfere with various cellular functions. Symptoms of poisoning appear 
6 to 24 hours after consumption, followed by a period of apparent improvement, and 
includes liver and kidney failure, which lead to death after four days or more. The DNA of 
A. bisporigera has been partially sequenced, and the genes responsible for the production 
of amatoxins have been identified; 
ii) Amanita exitialis is a deadly poisonous mushroom belonging to the large family of Amanitae. 
The highest content of toxic peptides are found in the cap and these peptides have been 
widely used in biological research as chemical agents to inhibit RNA polymerase II, an 
enzyme essential for protein synthesis; 
iii) Amanita fuliginea is a lethal poisonous mushroom responsible for most of the fatal 
mushroom poisoning incidents in Southern China. The toxic activity is due to several toxic 
peptides: α-amanitin, β-amanitin, amaninamide, phallacin, phallacidin, phallisacin, 
desoxoviroidin, and an additional uncharacterized phallotoxin; 
iv) Amanita phalloides is one of the most poisonous mushrooms known. It has been linked in 
the majority of human deaths from mushroom poisoning: half a mushroom contains enough 
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toxin to kill an adult human. Also known as the death cap, it is distributed worldwide, 
especially across Europe. The class of toxins found in these mushrooms, amatoxins, can 
cause hepatic and renal failure and are thermostable, so their toxic effects are not reduced 
by cooking; 
v) Amanita rimosa grows in a broad-leaved forest dominated by Fagaceae and this mushroom 
is only known from the type locality (China, Hunan Province, Yizhang County, Mangshan) 
at present. A remarkable feature of Amanita rimosa is its splitting cap surface, which is a 
result of the mushroom's having a slightly gelatinized upper layer of the cap's skin that 
includes abundant inflated cells. The major toxins of A. rimosa belong to the bicyclic 
octapeptides amatoxins, which act by binding non-competitively to RNA polymerase II, 
greatly slowing the elongation of transcripts from target promoters. 
Figure 11 histogram summarises the information about the number of proteins in the Main Collection 
on the basis of the organism producing them, while Table 19 exemplifies data summarised in the 
dedicated Organisms.xlsx file. 
 
Figure 11: Histogram of organism source of the proteins toxic per se 
 
Table 19: Extract of organisms table (MC_organisms.xlsx) 
UniProt Organism 
A0A1Q7CZY2 Actinobacteria bacterium 13_2_20CM_2_66_6 
A0A2S1FHS7 Polaromonas sp. E10S 
A0A351WVN6 Geobacter sp. 
A0A1F9GT57 Deltaproteobacteria bacterium RIFCSPHIGHO2_12_FULL_43_9 
A0A1M3BB20 Solirubrobacterales bacterium 70-9 
A0A3X1TZV0 Salmonella enterica 
… … 
UniProt: the UniProtKB identifier of the protein/peptide; Organism: organism that express the toxin. 
3.1.1.4. Gene ontology (GO) terms 
The GO terms (see Section 2.1.2) cover three domains: biological processes, molecular functions and 
cellular components. This information is important to understand the mechanism of action of the toxins 
and associated pathogenesis.  GOs for the identified proteins toxic per se (Main Collection) were 
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analysed according to these three categories (see Figures 12-14 reporting the frequencies of the 
individual GO in the Main collection of proteins). More than one GO can be associated with each toxin, 
while 18 retrieved proteins were found not to be associated with this GO term “toxin activity”. After 
careful inspection, it was observed that all these proteins are flaggable as toxins that belong to a toxin-
antitoxin system. Table 20 exemplifies data summarised in dedicated go.xlsx files. 
Table 20: Extract of GO terms table (MC_go.xlsx) 
UniProt ID GO 
A0A1Q7CZY2 Go:0000287 Magnesium ion binding 
A0A1Q7CZY2 Go:0004540 Ribonuclease activity 
A0A1Q7CZY2 Go:0090729 Toxin activity 
A0A2S1FHS7 Go:0000287 Magnesium ion binding 
A0A2S1FHS7 Go:0004540 Ribonuclease activity 
… … … 
UniProt: the UniProtKB identifier of the protein/peptide; ID: the Gene Ontology unique identifier; GO: the name of the GO. 
In the following sections, the most recurrent GOs for the identified proteins are reported: 
Molecular Function (Figure 12): 
i) toxin activity: interacts selectively with one or more biological molecules in another 
organism (the "target" organism), initiating pathogenesis (leading to an abnormal, generally 
detrimental state) in the target organism. The activity should refer to an evolved function 
of the active gene product, i.e. one that was selected for. Examples include the activity of 
botulinum toxin and snake venom; 
ii) ion channel inhibitor activity: stops, prevents, or reduces the activity of an ion channel; 
iii) metal ion binding: interacts selectively and non-covalently with any metal ion; 
iv) sodium channel inhibitor activity: stops, prevents, or reduces the activity of a sodium 
channel; 
v) calcium ion binding: interacts selectively and non-covalently with calcium ions (Ca2+). 
Except for toxin activity, it is interesting to point out that the most frequently found molecular functions 
of toxic proteins are related to channel inhibition activity and to ion binding. 
Biological process (Figure 13): 
i) defence response: reactions, triggered in response to the presence of a foreign body or the 
occurrence of an injury, which result in restriction of damage to the organism attacked or 
prevention/recovery from the infection caused by the attack; 
ii) hemolysis in other organism: the cytolytic destruction of red blood cells, with the release of 
intracellular hemoglobin, in one organism by another; 
iii) lipid catabolic process: the chemical reactions and pathways resulting in the breakdown of 
lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent; 
iv) arachidonic acid secretion: the controlled release of arachidonic acid from a cell or a tissue; 
v) phospholipid metabolic process: the chemical reactions and pathways involving 
phospholipids, any lipid containing phosphoric acid as a mono- or diester.  
Cellular component (Figure 14): 
i) extracellular region: the space external to the outermost structure of a cell. For cells without 
external protective or external encapsulating structures this refers to space outside of the 
plasma membrane. This term covers the host cell environment outside an intracellular 
parasite. 
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Figure 12: Frequency of the Molecular Function GO terms 
 
 
Figure 13: Frequency of the Biological Process GO terms  
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Figure 14: Frequency of the Cellular Component GO terms 
 
Defence response is the most frequently found biological process while Extracellular region is the most 
frequently found cellular component, in compliance with the GO-based definition of toxin. 
3.1.1.5. Keywords 
For each protein from the Main Collection, keywords were extracted from UniProtKB (unique ID and 
category) (see Table 21). UniProtKB keywords constitute a controlled vocabulary with a hierarchical 
structure, different from GO. Keywords are native of UniprotKB and summarize the content of a 
UniProtKB entry, facilitating the search for proteins of interest. Keywords were assigned by UniProtKB 
curators and are classified in 10 categories: 
- Biological process 
- Cellular component 
- Coding sequence diversity 
- Developmental stage 
- Disease 
- Domain 
- Ligand 
- Molecular function 
- Post-translational modification (PTM) 
- Technical term 
 
Table 21: Extract of keywords table (MC_keywords.xlsx) 
Uniprot ID Keyword Category 
A0A1Q7CZY2 KW-0378 Hydrolase Molecular function 
A0A1Q7CZY2 KW-0460 Magnesium Ligand 
A0A1Q7CZY2 KW-0479 Metal-binding Ligand 
A0A1Q7CZY2 KW-0540 Nuclease Molecular function 
A0A1Q7CZY2 KW-0800 Toxin Molecular function 
A0A1Q7CZY2 KW-1277 Toxin-antitoxin system Biological process 
A0A2S1FHS7 KW-0378 Hydrolase Molecular function 
A0A2S1FHS7 KW-0460 Magnesium Ligand 
… … … … 
UniProt: the UniProtKB identifier of the protein/peptide; ID: the keyword unique identifier; Keyword: the keyword; Category: the 
category in which the keyword is categorized. 
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An entry often contains several keywords. Within a category, the keywords are stored in alphabetical 
order. Some keywords are also related to GO. Figure 15 reports the count of all the keywords, not 
divided into categories. The following sections describe in more detail the main keywords, according to 
their frequency: 
i) Toxin 
Definition: Naturally-produced poisonous protein that damages or kills other cells, or the 
producing cells themselves in some cases in bacteria. Toxins are produced by venomous and 
poisonous animals, some plants, some fungi and some pathogenic bacteria. Animal toxins 
(mostly from snakes, scorpions, spiders, sea anemones and cone snails) are generally secreted 
in the venom of the animal. 
Category: Molecular function 
GO: toxin activity [GO:0090729] 
ii) Secreted 
Definition: Protein secreted into the cell surroundings. 
Category: Cellular component 
GO: extracellular region [GO:0005576] 
iii) Disulfide bond 
Definition: Protein, which is modified by the formation of a bond between the thiol groups of 
two peptidyl-cysteine residues. The process of chemical oxidation that forms interchain disulfide 
bonds can produce stable, covalently linked protein dimers, multimers or complexes, whereas 
intrachain disulfide bonds can contribute to protein folding and stability. Depending on the 
protein environment, some disulfide bonds are more labile, forming transient redox-active 
disulfide bonds that are alternately reduced and oxidized in the course of an enzymatic reaction. 
Category: PTM 
iv) Signal 
Definition: Protein, which has a signal sequence, a peptide usually present at the N-terminus of 
proteins and which is destined to be either secreted or part of membrane components. The 
signal sequence (usually 20-30 amino acids long) interacts with the signal recognition particle 
and directs the ribosome to the endoplasmic reticulum where co-translational insertion takes 
place. Signal peptides are highly hydrophobic but have some positively charged amino acids. 
Normally, the signal sequence is removed from the growing peptide chain by specific peptidases 
(signal peptidases) located on the cisternal face of the endoplasmic reticulum. 
Category: Domain 
v) Direct protein sequencing 
Definition: Protein, whose amino acid sequence has been partially (more than one residue) or 
completely determined experimentally by Edman degradation or by mass spectrometry. 
Category: Technical term 
vi) Neurotoxin 
Definition: Proteins, often exquisitely toxic, that inhibit neuronal function. Neurotoxins act 
typically against sodium channels or block or enhance synaptic transmission. Most venoms 
contain neurotoxic substances. 
Category: Molecular function 
vii) Ion channel impairing toxin 
Definition: Protein which interferes with the function of ion channels, which are hydrophilic 
channels across the lipid bilayer through which specific inorganic ions can diffuse down their 
electrochemical gradients. 
Category: Molecular function 
GO: ion channel inhibitor activity [GO:0008200] 
viii) Knottin 
Definition: Small disulfide-rich protein characterized by a special 'disulfide through disulfide 
knot'. This knot is obtained when one disulfide bridge crosses the macrocycle formed by two 
other disulfides and the interconnecting backbone (disulfide III-VI goes through disulfides I-IV 
and II-V). The knottin structure is found in some plant protease inhibitors, cyclotides, toxins 
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from cone snails, spiders, insects, horseshoe crabs and scorpions, gurmarin-like peptides, 
agouti-related proteins, and some antimicrobial peptides. 
Category: Domain 
ix) Hydrolase 
Definition: enzyme which catalyzes hydrolysis reaction, i.e. the addition of the hydrogen and 
hydroxyl ions of water to a molecule with its consequent splitting into two or more simpler 
molecules. 
Category: Molecular function 
GO: hydrolase activity [ GO:0016787 ] 
Figure 15: Frequency of keywords  
Full information on Keywords and their count can be found in the dedicated Excel files 
(MC_sequences.xlsx file). 
3.1.1.6. Three-dimensional structures 
Out of 6,964 proteins identified in this search, 765 have associated one or more experimentally-solved 
3D structure/s. As described in the Materials and methods section, 3D structures were carefully checked 
and only one structure was selected for each protein. Information about experimental determination of 
the structure such as method, resolution and percentage of sequence coverage were collected from the 
PDB source and are reported in a separate file (see Folder #1). Table 22 exemplifies the PDB table.  
Table 22: Extract of PDB table (see MC_pdb.xlsx) 
UniProt: PDB Method Resolution [Å] Experimental 
determination of 
the structure 
P01452 1cdt X-ray 2.5 100% 
P0DM15 2n7f NMR  100% 
P11494 2bds NMR  100% 
P10565 5foy X-ray 2.25 100% 
P10565 5foz X-ray 2.4 100% 
P10565 5g37 X-ray 2.5 100% 
P07231 1ad7 NMR  17% 
… … … … … 
UniProt: the UniProtKB identifier of the protein/peptide; PDB: the RCSB PDB identifier of the selected structure; Method: 3D 
structure determination method; Resolution: experimental resolution of the selected 3D structure; Experimental determination of 
the structure: percentage of primary structure covered by the 3D experimentally determined model.  
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Figure 16 briefly reports the number of experimentally-solved structures for each protein (labelled with 
its UniProtKB code), while Table 21 reports the number of available 3D structures in the PDB according 
to the structure determination methodology used. ‘Model’ belongs to an obsolete RCSB pdb policy under 
which also some theoretically-built models were available on the PDB source. This type of entry is now 
deprecated. As shown in Table 23, there are some toxins with associated two or more experimentally-
solved structures. 
Figure 16: Statistics of experimentally-solved structures per protein 
Table 23: Total number of experimentally-solved structures for protein toxins by method 
Method Number of experimentally-solved structures 
X-ray 1441 
NMR 586 
Model 55 
Electron microscopy 31 
Moreover, a total of 5,298 models were downloaded from the SM repository and stored into the 
Collection. There are some toxins with two or more associated models in the SM repository. As stated 
in the Materials and Methods section, in these cases we selected the model with the best quality check 
parameters for our in silico analysis. Information about the template, identity and percentage of 
sequence coverage are shown in summarizing Table 24 which also includes quality parameters. 
Table 24: Extract of SM table (See MC_swiss_models.xlsx) 
UniProt Template Identity Oligo Coverage Qmean Qmean 
norm 
Gmqe Origin 
P62377 1cvo.1.A 100% monomer 100% -6.9 0.3 0.99 SM 
P25681 1b41.1.B 93.4% monomer 100% 0.05 0.8 0.98 SM 
P0CG02 2mj4.1.A 70% monomer 100% -0.7 0.7 0.93 SM 
Q98962 1cb9.1.A 86.6% monomer 74% -1.1 0.7 0.69 SM 
Q9W716 1kxi.1.B 98.3% monomer 75% -0.2 0.8 0.75 SM 
Q53B57 1txb.1.A 85.0% monomer 74% -5.5 0.4 0.7 SM 
P62377 1cvo.1.A 100% monomer 100% -6.9 0.3 0.99 SM 
P25681 1b41.1.B 93.4% monomer 100% 0.05 0.8 0.99 SM 
… … … … … … … … … 
UniProt: the UniProtKB identifier of the protein/peptide; Template: the PDB code of the 3D protein structure used for homology 
modelling; Identity: percentage of identity between template and query; Oligo: ; Coverage: percentage normalized of the 
modelled structure coverage; Qmean(Benkert et al., 2011): parameter involved in the quality estimation (please, refer to 
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Methods); Qmean norm: parameter involved in the quality estimation; Gmqe: parameter involved in the quality estimation (please, 
refer to Methods); Origin: tool used for the homology modelling (SM = Swiss-Model; CPH = CPH Model). 
As shown in Figure 17, some templates were used to model different proteins (e.g. PDB ID: 2MDN) that 
belong to the same family.  
 
Figure 17: Statistics of crystallographic structure templates per protein 
3.1.1.7. Examples of entries in the Main Collection  
For each protein, biologically-relevant information was downloaded from UniProtKB. Two examples are 
reported below to distinguish between a well-described protein (MEL_APIME) and a poorly described 
one (DIS_CERVI). The examples are directly taken from the Main Collection (Annex A). The experimental 
or modelling-related information is listed in the respective Excel file (“MC_ pdb.xlsx”, see Table 15). 
P01501 (MEL_APIME) 
 
Figure 18: Melittin (green)forms pores by inserting itself into the membrane lipid bilayer (yellow). (PDB 
ID: 2MLT; membrane, water and ion were added with MOE only for a graphical representation) 
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Function 
Melittin (Figure 18): main toxin of bee venom with strong hemolytic and antimicrobial activity. It 
enhances the effects of bee venom phospholipase A2. This amphipathic toxin binds to negatively 
charged membrane surfaces and forms pores by inserting into lipid bilayers. This in turn induces the 
leakage of ions and molecules from the cells and increases its permeability, ultimately leading to cell 
lysis.  It acts as a voltage-gated pore with higher selectivity for anions over cations. The ion conductance 
has been shown to be voltage-dependent. Self-association of melittin in membranes is promoted by 
high ionic strength, but not by the presence of negatively charged lipids. In vivo, intradermal injection 
into healthy human volunteers produces sharp pain sensation and an inflammatory response.  It 
produces pain by activating primary nociceptor cells directly and indirectly due to its ability to activate 
plasma membrane phospholipase A2 and its pore-forming activity. 
Melittin-S: 1.4-fold less hemolytic and adopts a less organized secondary structure than melittin. 
Melittin-2: Has strong hemolytic activity. 
Miscellaneous 
N-formyl-melittin major has 80% of the activity of melittin. 
Melittin: The secretion of this protein into venom follows a seasonal pattern. This variation is 
synchronized with phospholipase A2 variation, i.e. their production increases in the same months. 
Melittin-S: The secretion of this protein into venom follows a seasonal pattern, the maximum secretion 
occurring during the (southern) winter months. 
Exists in two forms, due to cis-trans isomerization at 56-Leu-Pro-57. The trans conformation is the major 
form. The trans conformation is required for an alpha-helix.The derivative MelP5 is amidated. 
Pharmaceutical 
Melittin is an attractive candidate for cancer chemotherapy causing more damage to the tumor cell 
membranes since its membrane potential is higher and cells are less likely to develop resistance to a 
membrane pore formation. Despite this potential applicability of melittin, its rapid degradation in the 
blood and its non-specific cellular lytic activity - including hemolysis - poses significant challenges. 
However, melittin and/or its conjugates can work in conjunction with hormone receptors, gene therapy 
or as nanoparticles for targeted therapies of some cancer types. 
Similarity 
Belongs to the melittin family. 
Subcellular location 
Alpha-helical peptides form toroidal pores in the prey. 
Subunit 
Monomer (in solution and for integration into membranes), homotetramer (in solution and potentially 
as a toroidal pore in membranes), and potentially homomultimer (as a toroidal pore in membranes). 
Tissue specificity 
Expressed by the venom gland. 
Toxic dose 
LC(50) is 2.7 ug/ml against killifish. 
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Q3BK17 (DIS_CERVI) 
 
Figure 19: Structure of Q3BK17 obtained via homology modelling. This protein shows a Knottin 
architecture. 
Function 
Specifically interacts with the alpha-1/beta-1 integrin (ITGA1/ITGB1). Exhibits highly inhibitory effects 
on cell adhesion and cell migration to collagens I and IV. Also shows in vivo anti-angiogenic activity (By 
similarity) (Figure 19). 
Similarity 
Belongs to the disintegrin family. Short disintegrin subfamily. 
Subunit 
Monomer. 
Tissue specificity 
Expressed by the venom gland. 
3.1.1.8. Families, domains and signatures 
As described in Section 2.4, for each source, families/domains classification was carefully checked (Table 
25); redundancy among available sources was investigated leading us to conclude that Pfam can be 
considered the main reference source for protein family classification, while InterPro can be considered 
the most complete database for both domains and signatures clustering. The domain/signature 
classification in all the other databases mirrors that of Interpro, which is also the most up-to-date 
database. All the information extracted from both Pfam and InterPro is reported in Annex E and F, 
respectively, while Figures 20 and 21 show the number of proteins for each family or domain, 
respectively. Signatures are considered in the domain classification. 
Table 25: Number of clusters by database (See MC_databases.xlsx) 
Source Number of families/domains/signatures 
PFAM 288 
INTERPRO 599 
PROSITE 138 
CATH-GENE3D 8 
SUPFAM 94 
PRINTS 66 
SMART 62 
PANTHER 33 
TIGRFAMs 27 
PIRSF 25 
CDD 35 
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Figure 20: Number of toxins for each Pfam entry 
 
 
Figure 21: Number of toxins for each InterPro entry 
Some examples of Pfam results are reported below. All the family descriptions are extracted from the 
Pfam web site. Images were produced after primary structure-based alignment with Clustal Omega and 
3D structures superposition with MOE. Proteins are coloured according to RMSD within the structures 
of the family. For each family, a reference structure was selected to highlight architecture (domain 
composition), conserved within the family.  With regards to the toxins identified in the previous exercise, 
these toxins in the Main Collection can be classified into 290 families, in which 595 different domains 
can be found. Most of the identified protein families are multidomain, i.e. contain more than a single 
domain in the same architecture. The complete list of Pfam families and their description, can be found 
in Annex E. 
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Alpha-2-macroglobulin family (A2M) 
 
 
Figure 22: Superposition of A2M family members. Secondary structures are coloured according to 
RMSD (green represents low RMSD regions while red represents high RMSD regions)  
This family includes the C-terminal region of the alpha-2-macroglobulin family (Figure 22 and Table 
26).4 
Reference structure: Q0ZZJ6 
Table 26: Q0ZZJ6 architecture  
Source Domain Start End 
Pfam MG1 22 122 
Pfam MG2 127 216 
Pfam MG3 218 303 
Pfam MG4 345 435 
Pfam A2M_BRD 445 587 
Pfam ANATO 677 712 
Pfam A2M 754 850 
Pfam TED_complement 963 1263 
Pfam A2M_recep 1377 1472 
Pfam NTR 1513 1623 
 
A2M-BRD 
  
Figure 23: Superposition of A2M_BRD family members. Secondary structures are coloured according 
to RMSD (green represents low RMSD regions while red represents high RMSD regions)  
                                                 
4 Pfam definition 
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This family includes the C-terminal region of the alpha-2-macroglobulin family (as A2M) (Figure 23 and 
Table 27).  
Reference structure: Q0ZZJ6 
Table 27: Q0ZZJ6 architecture 
Source Domain  Start End 
Pfam MG1  22 122 
Pfam MG2  127 216 
Pfam MG3  218 303 
Pfam MG4  345 435 
Pfam A2M_BRD  445 587 
Pfam ANATO  677 712 
Pfam A2M  754 850 
Pfam TED_complement  963 1263 
Pfam A2M_recep  1377 1472 
Pfam NTR  1513 1623 
 
A2M_recep 
 
Figure 24: Superposition of A2M_recep family members. Secondary structures are coloured according 
to RMSD (green represents low RMSD regions while red represents high RMSD regions)  
This family includes the C-terminal region of the alpha-2-macroglobulin family (as A2M) (Figure 24 and 
Table 28).4  
Reference structure: Q0ZZJ6 
Table 28: Q0ZZJ6 architecture 
Source Domain Start End 
Pfam MG1 22 122 
Pfam MG2 127 216 
Pfam MG3 218 303 
Pfam MG4 345 435 
Pfam A2M_BRD 445 587 
Pfam ANATO 677 712 
Pfam A2M 754 850 
Pfam TED_complement 963 1263 
Pfam A2M_recep 1377 1472 
Pfam NTR 1513 1623 
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ATPase family associated with various cellular activities (AAA) 
 
Figure 25: AAA family member. Secondary structures are coloured according to Pfam-defined domains 
(light blues represents the AAA domain while grey represents other domains, since it is the only member 
of the AAA family classified as toxin and reviewed.)  
Proteins of the AAA family often perform chaperone-like functions that assist in the assembly, operation, 
or disassembly of protein complexes (Table 29).4 
Reference structure: q54316 (Figure 25) 
Table 29: q54316 architecture 
Source Domain Start End 
Pfam Clp_N 18 69 
Pfam Clp_N 94 146 
Pfam AAA 213 347 
Pfam AAA_lid_9 352 456 
Pfam AAA_2 545 717 
Pfam ClpB_D2-small 723 803 
Some examples of InterPro results are reported in the following lines. All the domain/signature 
descriptions are extracted from InterPro web site. For the complete list of domains and their description 
see Annex F. 
IPR000020 - Anaphylatoxin/fibulin - Domain. 2606 proteins. 
This entry represents C3a, C4a and C5a anaphylatoxins, which are protein fragments generated 
enzymatically in serum during activation of complement molecules C3, C4, and C5. They induce smooth 
muscle contraction. These fragments are homologous to a three-fold repeat in fibulins. 
Complement components C3, C4 and C5 are large glycoproteins that have important functions in the 
immune response and host defence. They have a wide variety of biological activities and are 
proteolytically activated by cleavage at a specific site, forming a- and b-fragments. a-fragments form 
distinct structural domains of approximately 76 amino acids, coded for by a single exon within the 
complement protein gene. The C3a, C4a and C5a components are referred to as anaphylatoxins: they 
cause smooth muscle contraction, histamine release from mast cells, and enhanced vascular 
permeability. They also mediate chemotaxis, inflammation, and generation of cytotoxic oxygen radicals. 
The proteins are highly hydrophilic, with a mainly alpha-helical structure held together by 3 disulphide 
bridges. 
Fibulins are secreted glycoproteins that become incorporated into a fibrillar extracellular matrix when 
expressed by cultured cells or added exogenously to cell monolayers. The five known members of the 
family share an elongated structure and many calcium-binding sites, owing to the presence of tandem 
arrays of epidermal growth factor-like domains. They have overlapping binding sites for several 
basement-membrane proteins, tropoelastin, fibrillin, fibronectin and proteoglycans, and they participate 
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in diverse supramolecular structures. The amino-terminal domain I of fibulin consists of three 
anaphylatoxin-like (AT) modules, each approximately 40 residues long and containing four or six 
cysteines. The structure of an AT module was determined for the complement-derived anaphylatoxin 
C3a, and was found to be a compact alpha-helical fold that is stabilised by three disulphide bridges in 
the pattern Cys1-4, Cys2-5 and Cys3-6 (where Cys is cysteine). The bulk of the remaining portion of 
the fibulin molecule is a series of nine EGF-like repeats. 
References: 
C5a fragment of bovine complement. Purification, bioassays, amino-acid sequence and other 
structural studies. Gennaro R, Simonic T, Negri A, Mottola C, Secchi C, Ronchi S, Romeo D. Eur. J. 
Biochem. 155 1 (1986) 77-86. PUBMED 3081348 
Sequence of the gene for murine complement component C4. Ogata RT, Rosa PA, Zepf NE. J. Biol. 
Chem. 264 28 (1989) 16565-72. PUBMED 2777798 
Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. Argraves 
WS, Tran H, Burgess WH, Dickerson K. J. Cell Biol. 111 6 Pt 2 (1990) 3155-64 . PUBMED 2269669 
Fibulins: a versatile family of extracellular matrix proteins. Timpl R, Sasaki T, Kostka G, Chu ML. Nat. 
Rev. Mol. Cell Biol. 4 6 (2003) 479-89. PUBMED 12778127 
Structure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like 
repeats and consensus motifs for calcium binding. Pan TC, Sasaki T, Zhang RZ, Fassler R, Timpl R, Chu 
ML. J. Cell Biol. 123 5 (1993) 1269-77. PUBMED 8245130 
Primary structure of cobra complement component C3. Fritzinger DC, Petrella EC, Connelly MB, 
Bredehorst R, Vogel CW. J. Immunol. 149 11 (1992) 3554-62. PUBMED 1431125 
IPR000101 - Gamma-glutamyltranspeptidase - Family. 28201 proteins. 
Gamma-glutamyltranspeptidase ([intenz:2.3.2.2]) (GGT) catalyzes the transfer of the gamma-glutamyl 
moiety of glutathione to an acceptor that may be an amino acid, a peptide or water (forming glutamate). 
GGT plays a key role in the gamma-glutamyl cycle, a pathway for the synthesis and degradation of 
glutathione and drug and xenobiotic detoxification. In prokaryotes and eukaryotes, it is an enzyme that 
consists of two polypeptide chains, a heavy and a light subunit, processed from a single chain precursor 
by an autocatalytic cleavage. The active site of GGT is known to be located in the light subunit. The 
sequences of mammalian and bacterial GGT show a number of regions of high similarity. Pseudomonas 
cephalosporin acylases ([intenz:3.5.1]) that convert 7-beta-(4-carboxybutanamido)-cephalosporanic 
acid (GL-7ACA) into 7-aminocephalosporanic acid (7ACA) and glutaric acid are evolutionary related to 
GGT and also show some GGT activity. Like GGT, these GL-7ACA acylases, are also composed of two 
subunits. This entry also includes the highly similar Scoloptoxin SSD14 from Scolopendra dehaani. 
SSD14 (which is also cleaved into alpha and beta subunits) has been shown to induce human platelet 
aggregation. 
As an autocatalytic peptidase GGT belongs to MEROPS peptidase family T3 (gamma-glutamyltransferase 
family, clan PB(T)). The active site residue for members of this family and family T1 is C-terminal to the 
autolytic cleavage site. The type example is gamma-glutamyltransferase 1 from Escherichia coli. 
References: 
Nucleotide sequence and expression in Escherichia coli of the cephalosporin acylase gene of a 
Pseudomonas strain. Ishiye M, Niwa M. Biochim. Biophys. Acta 1132 3 (1992) 233-9 . PUBMED 1358202 
DNA sequence of the Escherichia coli K-12 gamma-glutamyltranspeptidase gene, ggt. Suzuki H, 
Kumagai H, Echigo T, Tochikura T. J. Bacteriol. 171 9 (1989) 5169-72 . PUBMED 2570061 
gamma-Glutamyl transpeptidase from kidney. Tate SS, Meister A. Meth. Enzymol. 113 (1985) 400-19 
. PUBMED 2868390 
Gamma-glutamyltransferase: nucleotide sequence of the human pancreatic cDNA. Evidence for a 
ubiquitous gamma-glutamyltransferase polypeptide in human tissues. Courtay C, Oster T, Michelet F, 
Visvikis A, Diederich M, Wellman M, Siest G. Biochem. Pharmacol. 43 12 (1992) 2527-33 . PUBMED 
1378736 
Venomic and transcriptomic analysis of centipede Scolopendra subspinipes dehaani. Liu ZC, Zhang R, 
Zhao F, Chen ZM, Liu HW, Wang YJ, Jiang P, Zhang Y, Wu Y, Ding JP, Lee WH, Zhang Y. J. Proteome 
Res. 11 12 (2012) 6197-212 . PUBMED 23148443 
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IPR000126 - Serine proteases, V8 family, serine active site - Active_site. 1126 proteins. 
A number of prokaryotic proteases have been shown to be evolutionary related; their catalytic activity 
is provided by a charge relay system similar to that of the trypsin family of serine proteases but which 
probably evolved by independent convergent evolution. The sequence around the residues involved in 
the catalytic triad (aspartic acid, serine and histidine) are completely different from that of the analogous 
residues in the trypsin serine proteases and can be used as signatures specific to that category of 
proteases. The proteases which are known to belong to this family are listed below. 
This entry represents the serine active site of serine proteases from the V8 family. 
Staphylococcus aureus V8 proteinase, which preferentially cleaves peptide bonds on the carboxyl-
terminal side of aspartate and glutamate and which is widely used in protein sequencing studies. 
Bacillus licheniformis glutamate specific endopeptidase (GSE), which like V8 cleaves on the carboxyl-
terminal side of acidic residues, but with a strong preference for glutamate. 
Bacillus subtilis extracellular "metalloprotease" (gene mpr). 
Staphylococcus aureus exfoliative (or epidermolytic) toxins A (gene eta) and B (gene etb). These toxins 
cause impetigous diseases commonly referred to as staphylococcal scalded skin syndrome (SSSS) and 
have been shown to possess proteolytic activity. 
References: 
Isolation and amino acid sequence of a glutamic acid specific endopeptidase from Bacillus 
licheniformis. Svendsen I, Breddam K. Eur. J. Biochem. 204 1 (1992) 165-71 . PUBMED 1346764 
The epidermolytic toxins are serine proteases. Dancer SJ, Garratt R, Saldanha J, Jhoti H, Evans R. 
FEBS Lett. 268 1 (1990) 129-32 . PUBMED 2384148 
Gene encoding a novel extracellular metalloprotease in Bacillus subtilis. Sloma A, Rudolph CF, Rufo 
GA Jr, Sullivan BJ, Theriault KA, Ally D, Pero J. J. Bacteriol. 172 2 (1990) 1024-9 . PUBMED 2105291 
Chemistry of collagen cross-linking: biochemical changes in collagen during the partial mineralization 
of turkey leg tendon. Knott L, Tarlton JF, Bailey AJ. Biochem. J. 322 ( Pt 2) (1997) 535-42 . PUBMED 
9065774 
3.1.2. TAS Collection 
As detailed in Section 2.2.1, proteins belonging to a toxin-antitoxin system (TAS) are identified in 
UniProtKB by the keyword “Toxin-antitoxin system” This chapter summarizes findings on TAS proteins, 
as covered by the entries in the TAS Collection of additional Excel files (see Table 15). 
3.1.2.1. Number of proteins identified 
The data on the 627 proteins identified as belonging to a toxin-antitoxin system (Keyword “Toxin-
antitoxin system Reviewed:Yes”) were downloaded from the UniProtKB database (March 2020). Among 
them, 624 have precursors into their sequence. All the selected proteins are the toxic component of the 
toxin-antitoxin system. Full details are included in Annexes C, D and in the Excel files (see Table 15); 
an example is presented in Table 30 below.  
Table 30: Example of primary structure Table (See TC_sequences.xlsx) 
Uniprot Fragment Precursor Structure Length Experimental 
determination of 
the structure 
Best pdb 
Q46863  true Swiss Model 535 0%  
P62555   Swiss Model 101 0%  
Q46995   Swiss Model 72 0%  
P62553   PDB 72 50% 3tcj 
P64525    124 0%  
… … … … … … … 
Fragment: is used to classify if the protein is only a fragment of the primary sequence 
Precursor: (logic) does the toxin have a precursor? 
Structure: source of the selected structure download 
Length: number of amino acids of the primary structure 
Experimental determination of the structure: experimentally-derived part of the protein (in percentage with respect to the length 
of primary structure) 
Best pdb: the protein data bank code of the best resolved structure.  
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3.1.2.2. Sequence length 
As shown in Figure 26, ~95% of the identified proteins have a sequence length of less than 200 amino 
acids, while ~50% of those proteins are shorter than 100 amino acids. Only 5 proteins are shorter than 
20 amino acids and were not modelled (Figure 27). 
 
Figure 26: Histogram of the primary structure length for TAS proteins 
 
 
Figure 27: Histogram of the primary structure length for TAS proteins (up to 170 amino acids in length) 
 
3.1.2.3. Organisms 
Reviewing the information on the organisms that express the selected toxins, we found that the most 
representative (i.e. those expressing the highest number of toxins) is Mycobacterium tuberculosis (strain 
ATCC 25618 / H37Rv) (145 proteins), followed by Mycobacterium tuberculosis (strain CDC 1551 / 
Oshkosh) (95 proteins), Escherichia coli (67 proteins), Methanocaldococcus jannaschii (20 proteins) and 
Archaeoglobus fulgidus (19 proteins).  
Figure 28 shows the histogram summarising the information about the number of proteins in the TAS 
Collection on the basis of the organism producing them. In the below section, a brief description is 
reported for the five most representative organisms Table 31 exemplifies data summarised in the 
dedicated go.xlsx file (see Table 15). 
i) Mycobacterium tubercolosis is an acid-fast, obligate aerobic, non-motile, rod-shaped 
bacterium and it is the causative agent of tubercolosis. The non-replicating persistent 
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form is refractory to most drugs, and may be induced by hypoxia (oxygen depletion) 
and/or nitric oxide exposure; 
ii) Escherichia coli is a Gram-negative straight rod, which either uses peritrichous flagella 
for mobility or is nonmotile. Pathogenic E.coli strains are responsible for infection of the 
enteric, urinary, pulmonary and nervous systems; 
iii) Methanocaldococcus jannaschii is a thermophilic methanogenic archaean, meaning that 
it grows by making methane as a metabolic by-product, in the class Methanococci; 
iv) Archaeoglobus fulgidus is the first sulphur-metabolizing organism to have its genome 
sequence determined. When subjected to stress, Archaeoglobus fulgidus can produce 
biofilms that have been applied for industrial purposes e.g. detoxifying contamination 
by metals; since it can survive at extremely high temperatures, there are hopes that 
heat stable enzymes may be derived from it. 
 
Table 31: Extract of organisms table (TC_organisms.xlsx) 
UniProt Organism 
P64524 Escherichia coli (strain K12) 
P62555 Escherichia coli O157:H7 
O34853 Bacillus subtilis (strain 168) 
P39394 Escherichia coli (strain K12) 
Q4QNL8 Haemophilus influenzae (strain 86-028NP) 
P9WF90 Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) 
… … 
UniProt: the UniProtKB identifier of the protein/peptide; Organism: organism of the organism that express the toxin. 
 
Figure 28: Histogram of organism source of TAS proteins 
 
3.1.2.4. Gene ontology (GO) terms 
The GO terms (see Section 2.1.2) cover three domains: molecular function biological processes, and 
cellular components. GOs for the TAS proteins (TAS collection) were analysed according to these 
categories (see Figures 29-31 report the frequencies of the individual GOs in the TAS Collection). More 
than one GO can be associated with each toxin. Table 32 exemplifies data summarised in dedicated 
go.xlsx files (see Table 15). 
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Table 32: Extract of GO terms table (see TC_go.xlsx) 
UniProt ID GO 
P64524 GO:0008092 cytoskeletal protein binding 
P62555 GO:0008657 
DNA topoisomerase (ATP-
hydrolyzing) inhibitor activity 
Q46995 GO:0003677 DNA binding 
Q8FDB5 GO:0003700 
DNA-binding transcription factor 
activity 
Q8FDB5 GO:0097351 toxin-antitoxin pair type II binding 
… … … 
UniProt: the UniProtKB identifier of the protein/peptide; ID: the Gene Ontology unique identifier; GO: the name of the GO. 
 
In the following section, the most recurrent GOs for the identified proteins are reported for each 
category: 
Molecular Function 
i) magnesium ion binding: interacting selectively and non-covalently with magnesium (Mg) ions;  
ii) ribonuclease activity: catalysis of the hydrolysis of phosphodiester bonds in chains of RNA; 
iii) DNA binding: any molecular function by which a gene product interacts selectively and non-
covalently with DNA (deoxyribonucleic acid); 
iv) endonuclease activity: catalysis of the hydrolysis of ester linkages within nucleic acids by 
creating internal breaks; 
v) RNA binding: interacting selectively and non-covalently with an RNA molecule or a portion 
thereof. 
Biological Process 
i) regulation of transcription, DNA-templated: any process that modulates the frequency, 
rate or extent of cellular DNA-templated transcription; 
ii) negative regulation of growth: any process that stops, prevents or reduces the rate or 
extent of growth, the increase in size or mass of all or part of an organism; 
iii) positive regulation of growth: any process that activates or increases the phospholipid 
metabolic process: the chemical reactions and pathways involving phospholipids, any lipid 
containing phosphoric acid as a mono- or diester.  
Cellular Component 
i) plasma membrane: the membrane surrounding a cell that separates the cell from its external 
environment. It consists of a phospholipid bilayer and associated proteins; 
ii) integral component of membrane: the component of a membrane consisting of the gene 
products and protein complexes having at least some part of their peptide sequence 
embedded in the hydrophobic region of the membrane; 
iii) extracellular region: the space external to the outermost structure of a cell. For cells without 
external protective or external encapsulating structures this refers to space outside of the 
plasma membrane. This term covers the host cell environment outside an intracellular 
parasite. 
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Figure 29: Frequency of the Molecular Function GO terms 
 
 
 
Figure 30: Frequency of the Biological Process GO terms 
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Figure 31: Frequency of the Cellular Component GO terms 
 
3.1.2.5. Keywords 
For each protein from the TAS collection, keywords were extracted from UniProtKB (unique ID and 
category) (Table 33). UniProtKB keywords constitute a controlled vocabulary with a hierarchical 
structure, different from GO. Keywords are native of UniprotKB and summarize the content of a 
UniProtKB entry, facilitating the search for proteins of interest. Keywords were assigned by UniProtKB 
curators and are classifiable in 8 categories: 
- Toxin-antitoxin system 
- Complete proteome  
- Reference proteome 
- Hydrolase 
- Nuclease 
- Metal-binding 
- Magnesium 
- 3D-structure 
 
Table 33: Extract of keywords table (TC_keywords.xlsx) 
Uniprot ID Keyword Category 
P64524 KW-0133 Cell shape Biological process 
P64524 KW-0181 Complete proteome Technical term 
P64524 KW-0963 Cytoplasm Cellular component 
P64524 KW-1185 Reference proteome Technical term 
P64524 KW-1277 Toxin-antitoxin system Biological process 
P62555 KW-0181 Complete proteome Technical term 
… … … … 
UniProt: the UniProtKB identifier of the protein/peptide; ID: the keyword unique identifier; Keyword: the keyword; Category: the 
category in which the keyword is categorized. 
An entry often contains several keywords. Within a category, the keywords are stored in alphabetical 
order. Some keywords are also related to GO. Figure 32 reports the count of all the keywords, not 
divided into categories. The following section describes in more detail the main keywords based on their 
frequency (>100 counts): 
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i) Toxin-antitoxin system  
Definition: Bacterial, archaeal or viral protein belonging to a toxin-antitoxin (TA) system. Toxin 
protein expression is poisonous to the cell and is counteracted by its co-expressed, short-lived 
"antidote" antitoxin. Antitoxins can be protein (type II, IV, V, VI) or RNA (type I, III) and act 
directly or indirectly on the toxin protein or transcript. Genes for the two components are closely 
linked; in many type II TA systems the toxin-antitoxin complex regulates transcription of its 
operon. Toxins belong to recognizable protein families, antitoxins usually do not. Orphan toxin 
genes are occasionally found in complete genomes. 
Category: Biological process 
ii) Complete proteome 
Definition: Protein which is part of a proteome. A proteome is the set of protein sequences that 
can be derived by translation of all protein coding genes of a completely sequenced genome, 
including alternative products such as splice variants for those species in which these may occur. 
Proteomes may include protein sequences from both the reviewed (UniProtKB /Swiss-Prot) and 
unreviewed (UniProtKB/TrEMBL) sections of the UniProt Knowledgebase. Note that some 
proportion of the predicted protein sequences of a given proteome may require further review 
or correction. The precise proportion depends on the relative distributions of protein sequences 
between the two sections of UniProtKB and the quality of the underlying genome sequence and 
gene predictions. 
Category: Technical term 
iii) Reference proteome 
Definition: Protein which is part of a reference proteome. Reference proteomes are a subset of 
proteomes that have been selected either manually or algorithmically according to a number of 
criteria to provide a broad coverage of the tree of life and a representative cross-section of the 
taxonomic diversity found within UniProtKB, as well as the proteomes of well-studied model 
organisms and other species of interest for biomedical research. 
Category: Technical term 
iv) Hydrolase 
Definition: Enzyme which catalyzes hydrolysis reaction, i.e. the addition of the hydrogen and 
hydroxyl ions of water to a molecule with its consequent splitting into two or more simpler 
molecules. 
Category: Molecular function 
GO: hydrolase activity [GO:0016787] 
v) Nuclease 
Definition: Enzyme that degrades nucleic acids into shorter oligonucleotides or single nucleotide 
subunits by hydrolyzing sugar-phosphate bonds in the nucleic acid backbone. 
Category: Molecular function 
GO: nuclease activity  
vi) Metal-binding 
Definition: Protein which binds metals. 
Category: Ligand 
GO: metal ion binding  
vii) Magnesium 
Definition: Protein which binds at least one magnesium atom, or protein whose function is 
magnesium-dependent. Magnesium is a metallic element, chemical symbol Mg. 
Category: Ligand 
viii) 3D-structure 
Definition: Protein, or part of a protein, whose three-dimensional structure has been resolved 
experimentally (for example by X-ray crystallography or NMR spectroscopy) and whose 
coordinates are available in the PDB database. Can also be used for theoretical models. 
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Figure 32: Frequency of keywords 
Full information on Keywords and their count can be found in the dedicated Excel files 
(TC_sequences.xlsx file) 
3.1.2.6. Three-dimensional structures 
Out of the 627 identified TAS proteins, 114 have associated one or more experimentally-derived 3D 
structures. As described in the Materials and methods section, 3D structures were carefully checked and 
only one structure was selected for each protein. Information about the experimental determination of 
the structure such as method, resolution and percentage of sequence coverage were collected from the 
PDB source (see Table 15). Table 34 exemplifies the PDB table.  
 
Table 34: Extract of PDB table (see TC_pdb.xlsx) 
UniProt PDB Method Resolution [Å]  Experimental 
determination of 
the structure 
P62553 3tcj X-ray 1.93 50% 
O34853 3o6q X-ray 2.5 63.3% 
E6Z0R3 3shg X-ray 1.5 41.2% 
P9WFA5 6a7v X-ray 1.67 99.3% 
Q8U3V0 1y82 X-ray 2.3 99.3% 
A0A140NAP5 4ml0 X-ray 2.1 100% 
O53778 5x3t X-ray 2.65 100% 
… … … … … 
UniProt: the UniProtKB identifier of the protein/peptide; PDB: the RCSB PDB identifier of the selected structure; Method: 3D 
structure solving method; Resolution: resolution of the selected 3D structure; Experimental determination of the structure: 
percentage of protein sequence covered in the experimentally-solved structure.  
Figure 33 reports the number of experimentally-determined structures for each protein (labelled with 
its UniProtKB code), while Table 35 reports the number of available 3D structures in the PDB according 
to the determination methodology used. ‘Model’ belongs to an obsolete RCSB pdb policy under which 
also some protein theoretically-built models were available on the PDB source. This type of entry is now 
deprecated. 
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Figure 33: Statistic of experimentally-determined structures per protein. 
 
Table 35: Total number of experimentally-solved structures by method 
Method Number of experimentally-solved structures 
X-ray 256 
NMR 19 
Model 3 
Moreover, a total of 356 models were downloaded from the SM repository and stored into the TAS 
Collection. Also in this case there are some TAS proteins with 2 or more associated models in the SM 
repository. As stated in the Materials and Methods section, for our in silico analysis, we selected the one 
with best quality check parameters. 
Information about the template, identity and percentage of sequence coverage are shown in a 
summarizing table that also includes quality parameters (Table 36). 
Table 36: Extract of SM table (see TC_swiss-models.xlsx) 
UniProt Template Identity Oligo Coverage Qmean Qmean 
norm 
Gmqe Origi
n 
P9WF86 5wzf.1.a 17.3 Homo-2-mer 0.917 -3.898 0.616 0.502 SM 
P39394 4qo6.1.a 30.9 Monomer 0.513 -1.649 0.661 0.293 SM 
Q4QNL8 6nkl.1.c 44.2 Monomer 0.948 -1.837 0.677 0.554 SM 
P9WF90 5sv2.1.a 99.2 Homo-2-mer 0.978 -0.554 0.751 0.981 SM 
Q9Z4V7 3d55.1.c 63.4 Heteromer 0.781 -0.503 0.760 0.78 SM 
P0CW38 5g5s.1.a 100 Monomer 0.982 -0.172 0.781 0.985 SM 
… … … … … … … … … 
UniProt: the UniProtKB identifier of the protein/peptide; Template: the PDB code of the 3D protein structure used for homology 
modelling; Identity: percentage of identity between template and query sequence; Oligo: ; Coverage: percentage normalized of 
the modelled structure coverage; Qmean(Benkert et al., 2011): parameter involved in the quality estimation (see Methods); 
Qmean norm: parameter involved in the quality estimation; Gmqe: parameter involved in the quality estimation (see Methods); 
Origin: tool used for the homology modelling (SM = Swiss-Model; CPH = CPH Model). 
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As shown in Figure 34, some templates were used to model different proteins (e.g. PDB ID: 2FE1) that 
belong to the same family.  
 
 
Figure 34: Statistics of experimentally-solved structures per protein 
 
3.1.2.7. Families, domains and signatures 
For each source (Table 37), families/domains classification was carefully checked and Pfam was selected 
as the reference source for protein families, while InterPro was chosen as the reference source for both 
domains and signatures. All the other domain databases can be reported to the classification in InterPro, 
which is also the most up-to-date database. All the information extracted from both Pfam and InterPro 
is reported in Annex E and F, respectively, while Figures 35 and 36 show the number of proteins for 
each family or domain, respectively. Signatures are considered in the domain classification. 
Table 37: Number of families/domains by database (see TC_databases.xlsx) 
Source Number of families/domains/signatures 
PFAM 92 
INTERPRO 159 
PROSITE 11 
CATH-GENE3D 1 
SUPFAM 21 
PRINTS 2 
SMART 9 
PANTHER 17 
TIGRFAMs 21 
PIRSF 12 
CDD 7 
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Figure 35: Number of toxins for each Pfam entry 
 
 
 
Figure 36: Number of toxins for each InterPro entry 
 
For each protein, information was downloaded from UniProtKB and linked to the literature. Below, two 
examples are reported to distinguish between a well-annotated protein (Q46865) and a poorly-
annotated one (P0A7G6). All the information extracted is reported in Annex C. 
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Q46865 (MQSR_ECOLI) 
 
Figure 37: Crystallographic structure of Q46865 (PDB ID: 3HI2). 
 
Function 
Toxic component of a type II toxin-antitoxin (TA) system (Figure 37). Plays a significant role in the 
control of biofilm formation and induction of persister cells in the presence of antibiotics. An mRNA 
interferase which has been reported to be translation independent. It has also been reported to be 
translation dependent. Cleavage has been reported to occur on either side of G in the sequence GCU. 
Also reported to cleave after C in GC(A/U) sequences. There are only 14 genes in E.coli W3110 (and 
probably also MG1655) that do not have a GCU sequence and thus are resistant to the mRNA interferase 
activity; among these is the gene for toxin GhoT. Overexpression of MqsR causes cessation of cell 
growth and inhibits cell proliferation via inhibition of translation as well as increasing persister cell 
formation; these effects are overcome by concomitant or subsequent expression of antitoxin MqsA. 
Cross-talk can occur between different TA systems. Ectopic expression of this toxin induces transcription 
of the relBEF TA system operon with specific cleavage of the relBEF mRNA produced. Regulates the 
expression of GhoT/GhoS, a type V TA system. Persistence depends on toxin GhoT activity, which MqsR 
controls at the post-transcriptional level by selectively degrading the antitoxin ghoS segment of the 
ghoST mRNA. Persister cells exhibit antibiotic tolerance without genetic change. mRNA interferases play 
a role in bacterial persistence to antibiotics; overexpression of this protein induces persisters resistant 
to coiprofloxacin and ampicillin. Overexpression leads to a dramatic increase in tolerance to the antibiotic 
ofloxacin. This TA system mediates cell growth during bile acid deoxycholate stress by degrading mRNA 
for probable deoxycholate-binding protein YgiS; bile acid detergents such as deoxycholate are important 
for host defense against bacterial growth in the gall bladder and duodenum. 
Initially reported to act as a cotranscription factor with MqsA. Following further experiments, the MqsR-
MqsA complex does not bind DNA and all reported data are actually due to a small fraction of free MqsA 
alone binding DNA. Addition of MqsR to a preformed MqsA-promoter DNA complex causes dissociation 
of the MqsA-DNA complex, probably causing derepression of MqsA-repressed transcripts. Does not bind 
DNA in the presence or absence of MqsA. 
Temperature dependence 
The MqsR-MqsA complex is exceptionally thermostable with a Tm of 83.4 degress Celsius versus 48.1 
degrees Celsius for MqsR and 61.1 degrees Celsius for MqsA. 
Disruption phenotype 
No loss of ability to form persister cells in MG1655, represses persister cell formation in BW25113. 
Deletion decreases biofilm formation in LB medium. Deletion has also been shown to increase biofilm 
formation. Deletion at 48h, in flow cells, leads to a reduction in biomass, substratum coverage and 
changes the biofilm architecture from a 54-micron thick film with microcolonies to one with nearly no 
biomass and only a few colonies remaining. Deletion abolishes motility. A double mqsR-mqsA deletion 
leads to increased rpoS mRNA levels, resulting in increased cyclic-di-GMP levels, increasing stress 
resistance, increased biofilm formation. The double mutant has increased metabolism and respiration 
in the presence of the bile acid deoxycholate and consequently grows less well. Decreases cell survival 
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in the presence of 20% deoxycholate. mRNA interferases play a role in bacterial persistence to 
antibiotics; as 10 mRNA interferases are successively deleted reduced levels of persisters are generated. 
Expression - Induction 
Induced by amino acid starvation, glucose starvation and when translation is blocked. Also induced by 
nalidixic acid, azolocillin and H2O2. It has been suggested that MqsA represses its own operon. Induction 
is decreased in the absence of the Lon protease suggesting, by homology to other toxin-antitoxin 
systems, that Lon may degrade the MqsA antitoxin. Transcription is activated by MqsA. A member of 
the mqsRA operon. Most highly induced gene in persister cells. Degrades its own transcript. This operon 
induced by ectopic expression of toxins RelE, HicA and YafQ but not by MazF or HicA. 
Subunit structure 
Might be a dimer. Also reported to be a monomer. Crystallizes as a heterotetramer with MqsA, MqsR-
MqsA2-MqsR. Purifies as a possible heterohexamer of 2 MqsR dimers and 1 MqsA dimer. When the 2 
dissociate the MsqR mRNA interferase becomes active. 
 
P0A7G6 (RECA_ECOLI)  
 
 
Figure 38: Crystallographic structure of P0A7G6 (PDB ID: 1U98). 
 
Function 
Required for homologous recombination and the bypass of mutagenic DNA lesions by the SOS response. 
Catalyzes ATP-driven homologous pairing and strand exchange of DNA molecules necessary for DNA 
recombinational repair (Figure 38). Catalyzes the hydrolysis of ATP in the presence of single-stranded 
DNA, the ATP-dependent uptake of single-stranded DNA by duplex DNA, and the ATP-dependent 
hybridization of homologous single-stranded DNAs. The SOS response controls an apoptotic-like death 
(ALD) induced (in the absence of the mazE-mazF toxin-antitoxin module) in response to DNA damaging 
agents that is mediated by RecA and LexA. 
Activity regulation 
The rate of DNA-strand exchange is stimulated by RadA.  
Disruption phenotype 
Triple mazE-mazF-recA mutant cells no longer undergo an apoptotic-like death upon DNA damage 
characterized by membrane depolarization. 
Induction 
Induced by DNA damage, repressed by LexA. Induced in response to low temperature. Sensitive to 
temperature through changes in the linking number of the DNA. Induced by cold shock (42 to 15 
degrees Celsius) (at protein level). 5.1-fold induced by hydroxyurea treatment (at protein level). mRNA 
levels are repressed in a mazE-mazF-mediated manner. 
 
Below some examples of Pfam results are reported. All the family/domain descriptions are extracted 
from Pfam web site. For the complete list of families and their description, please, see Annex F.  
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CbtA_toxin of type IV toxin-antitoxin system 
CbtA is a family of bacterial and archaeal toxins of type IV toxin-antitoxin system. Toxins from such 
systems in free-living bacteria inhibit cell growth by targeting essential functions of cellular metabolism. 
In this case the toxin inhibits cell-division leading to changes in morphology and finally lysis, by 
interacting with two essential cytoskeletal proteins, FtsZ and MreB. For FtsZ it inhibits its GTPase activity 
and GTP-dependent polymerisation, and for MreB it inhibits its ATP-dependent polymerisation. These 
actions of CbtA appear to occur simultaneously. The cognate antitoxin family is represented by PF06154 
(Table 38). 
 
Reference structure: P77692 
 
Table 38: P77692 architecture 
Source Domain Start End 
Pfam CbtA_toxin 1 112 
 
On the other hand, some examples of InterPro results are reported in the following lines. All the 
domain/signature descriptions are extracted from InterPro web site. For the complete list of domains 
and their description, please, see Annex G. 
 
P64524 - Cytoskeleton-binding toxin CbtA - Escherichia coli (strain K12) 
disruption phenotype 
No visible phenotype. Deletion of 3 type IV toxin genes (cbtA, ykfI, ypfJ) leads to a slight reduction 
in resistance to oxidative stress, has no effect on cell growth. 
domain 
The N-terminal 15 residues are required for interaction with both FtsZ and MreB, while the C-terminal 
63 residues are required for interaction with MreB. 
function 
Toxic component of a type IV toxin-antitoxin (TA) system. Acts as a dual toxin inhibitor that blocks 
cell division and cell elongation in genetically separable interactions with FtsZ and MreB. Interacts with 
cytoskeletal proteins FtsZ and MreB; inhibits FtsZ GTP-dependent polymerization and GTPase activity 
as well as MreB ATP-dependent polymerization. Binds to both the N- and C-terminus of FtsZ, likely 
blocking its polymerization and localization, leading to blockage of cell division. Overexpression results 
in inhibition of growth in liquid cultures and decrease in colony formation; these effects are overcome 
by concomitant expression of antitoxin CbeA (YeeU). In other experiments cells swell, by 6 hours are 
lemon-shaped and by 24 hours those that have not lysed are spherical with diminished polar regions. 
Toxic effects are neutralized by cognate antitoxin CbeA, although there is no direct interaction between 
the 2 proteins. Toxic effects are also neutralized by overexpression of noncogate antitoxins YafW and 
YpjF. 
induction 
Expressed in mid-log phase at lower levels than toxin relE. 
miscellaneous 
Encoded in prophage CP4-44. 
similarity 
Belongs to the CbtA/YkfI/YpjF toxin family. 
subunit 
Interacts with FtsZ. Interacts with MreB. 
 
P62555 - Toxin CcdB - Escherichia coli O157:H7 
function 
Toxic component of a type II toxin-antitoxin (TA) system, functioning in plasmid maintainence. 
Responsible for the post-segregational killing (PSK) of plasmid-free cells, also referred to as a plasmid 
addiction system. Half-life of over 2 hours. Interferes with the activity of DNA gyrase, inducing it to form 
a covalent GyrA-DNA complex that cannot be resolved, thus promoting breakage of plasmid and 
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chromosomal DNA. Toxicity is inhibited by labile antitoxin CcdA, which blocks the activity of CcdB; CcdA 
also removes bound CcdB protein from the CcdB-GyrA complex by forming a CcdA-CcdB complex, a 
process termed rejuvenation. Functions as a transcriptional corepressor for the ccdAB operon, 
repression also requires CcdA (By similarity). 
similarity 
Belongs to the CcdB toxin family. 
subunit 
Homodimer. Forms a complex with GyrA, probably a tetramer GyrA(2)CcdB(2), in which GyrA is 
inactive. Forms a complex with toxin CcdB; the CcdA-CcdB(2) trimer is sufficient for rejuvenation, 
whereas maximal operon repression occurs with CcdA(2)CcdB(2) (By similarity). 
 
Q46995 - Antitoxin CcdA - Escherichia coli 
function 
Antitoxin component of a type II toxin-antitoxin (TA) system which inhibits the post-segregational 
killing (PSK) of plasmid-free cells, also referred to as a plasmid addiction system. Binds to and blocks 
the activity of CcdB; will also remove bound CcdB protein from the CcdB-GyrA complex by forming a 
CcdA-CcdB complex, a process termed rejuvenation. Functions as a transcriptional corepressor for the 
ccdAB operon, repression also requires CcdB (By similarity). 
similarity 
Belongs to the CcdA antitoxin family. 
subunit 
Homodimer in solution and when bound to DNA. Forms a complex with toxin CcdB; the CcdA-CcdB(2) 
trimer is sufficient for rejuvenation, whereas maximal operon repression occurs with CcdA(2)CcdB(2) 
(By similarity). 
3.2. Proteins with putative toxic activity as aggregates 
Some human pathologies are associated with the presence in the affected tissues of insoluble protein 
formations, whose components are sometimes referred to as ‘toxic proteins’. In the majority of cases 
such formations are highly structured aggregates, known as amyloid deposits; in other cases they 
feature unstructured aggregates. In accordance with this evidence, amyloidosis and aggregation were 
explored, giving rise to the below results.  
Amyloidosis 
The tendency of individual proteins to aggregate into amyloid fibrils varies. Some proteins are non-
amyloidogenic when present at their physiological concentration but become amyloidogenic at higher 
concentration. This is for instance the case of serum amyloid A, an acute phase protein whose circulating 
levels sustainedly increase in the course of chronic inflammation; of beta-2-microglobulin, a 99 aa 
polypeptide chain that, in the kidneys, is filtered by the glomerulus to be reabsorbed down the tubules, 
and whose circulating levels increase in patients on long-term hemodialysis; of complete 
immunoglobulins and/or portions thereof, which are produced in clonally homogenous form and at high 
concentration by plasma cells in the course of multiple myeloma (hence the term of M-proteins). Some 
proteins may form amyloid deposits at physiological concentrations when proteostasis become 
defective, such as in older age. This is for instance the case of wild-type transthyretin in senile 
amyloidosis and possibly of all proteins involved in neurodegenerative conditions of the elderly. 
Mutations in precursor genes may increase the degree of amyloidogenicity of the proteins described 
above and of other proteins; however, there are some reported cases of mutations that decrease the 
amyloidogenetic potential. The most relevant example for both outcomes is transthyretin, for which 
more than 50 amyloidogenic, and a handful of anti-amyloidogenic mutants have been described. The 
quaternary homotetrameric structure of transthyretin involves the association of two monomers then 
the association of two dimers. The dimer-dimer interfaces define two binding sites for the protein 
ligands; occupancy of one or both sites by natural or artificial ligands stabilizes the assembly. Conversely, 
apo-transthyretin is prone to dissociation and the dissociated subunits are in turn prone to partial 
unfolding/misfolding, which is instrumental to aggregation into amyloid fibrils. Among the artificial 
ligands interfering with the above processes, tafamidis (2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-
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carboxylic acid) is being marketed since 2011 to delay amyloid deposition and neurological sequels in 
carriers of transthyretin amyloidogenetic mutations. 
In a few cases amyloid fibers are made up not by individual components but by an assortment of 
proteins. The likely reason behind this presentation is an increased rate of cellular death, entailing the 
impossibility for the tissues to clear all the cellular debris. For instance, in some cutaneous forms of 
amyloidosis, the main components of the amyloid fibers are keratin and immunoglobulins together with 
serum amyloid P (SAP). Actually, the latter protein binds to all types of amyloid fibrils in a calcium-
dependent, reversible manner, and stabilizes them. 
The above background guided our search for proteins that are associated with amyloidosis – and that 
for this reason may be defined as ‘toxic’ to tissues/organisms. Our search in UniProt database was made 
with the string: « amyloidosis AND reviewed:yes », and retrieved 71 entries; of these, 44 are human 
proteins and 6 more are primate proteins (1 of Macaca fascicularis / Cynomolgus monkey, 4 of Macaca 
mulatta / Rhesus macaque, 1 of Saimiri sciureus / squirrel monkey), 4 are from hamster, 4 are murine 
and 2 bovine proteins. We downloaded the list with the main information for each of them: Entry; Entry 
name; Status; Protein names; Gene names; Organism; Length. 
We reviewed the list by inspecting the content of each entry. We rated as positive hit each protein that 
is reported to form amyloid fibrils by itself; we divided such entries as positive in the wild-type sequence 
and positive in one or more mutated natural variants. While in some cases also mutagenesis has been 
carried out on the gene, in our classification we did not take note of mutagenesis data. We rated as 
negative hit each protein that is not reported to form amyloid fibrils by itself, but that is instead able to 
start events whose final outcome is amyloidogenesis (25 entries). 
In 7 cases the term ‘amyloid’ could not be retrieved inside any field of the protein entry. Two such cases 
refer to parts of immunoglobulins, one to a fragment of apolipoprotein E (in a monkey) so the properties 
are likely to reflect what is known for the human protein of that name as a whole. In 3 cases we could 
find information about the direct or indirect involvement of the protein in amyloidosis referring to general 
scientific literature. In one case we could not find any such link. 
Aggregation of human proteins 
The term ‘aggregat(ion)’ is much broader than ‘amyloidosis’ and as such it is likely to yield many false 
positive hits. The word, in fact, is used to describe not only some pathologic events involving proteins 
but also a few physiologic processes involving various biological items. 
With reference to physiological processes, the most systematic and specific use of ‘aggregation’ refers 
to platelet function: in the final step of hemostasis, activated platelets with exposed GPIIb/IIIa bind 
fibrinogen and do aggregate. It was then straightforward to exclude from the output all UniProt entries 
connected with hemostasis by including in the search string the words ‘NOT platelet’. Conversely, we 
could not find any other general term that could be used to omit whole groups of proteins from the 
search. The more than 300 entries retrieved were thus inspected one by one. 
As anticipated, most of the proteins in the output turned out to be false positive hits (289/337). 
In many cases ‘aggregation’ was actually found in the entry, but it referred to such biological items as 
organelles, e.g. mitochondria, or cells, e.g. in homotypic recognition through adhesion molecules. In 
some cases, along the lines intended by our search, it did refer to proteins, still ‘aggregation’ was used 
to describe the way their biological function is actually carried out through interaction/binding/complex 
formation with similar or with different macromolecules, either at baseline or as a reaction to specific 
stress conditions. In a number of cases the protein was described as being able to prevent the 
aggregation of another protein, e.g. by acting as a chaperone; in a couple of cases, to cause the 
aggregation of another protein. 
In many cases ‘aggregation’ was found as being the hallmark of a disease and mutations/natural 
variants of the protein were reported to either predispose to the disease or to be its cause; however, 
the protein dealt with in the test entry was not reported as specifically prone to form pathological 
aggregates. 
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Only in a minority of cases, pathological aggregates of the protein itself were reported as pathological 
feature of a disease, and this was almost invariably connected with specific variants of the protein rather 
than with the wild-type form; even in several such cases, however, aggregation was associated with 
some but not all of the variants defined as cause of the relevant disease, so that the presence of protein 
aggregates per se seems unlikely to be the reason of the clinical findings (rather than e.g. the reduced 
availability/activity of the free protein). In a very large number of cases (72) ‘aggregation’ could not be 
found in any of the fields of the UniProt entry. Some of the relevant proteins were part of a complex, 
some were reported to bind other (macro)molecules so that it could be assumed that in these cases 
‘aggregation’ could have been taken as equivalent to interaction/binding/complex 
formation/polymerization and the like. For some other proteins, however, no obvious reason for such a 
discrepancy was evident. 
Aggregation of animal proteins 
After collecting the properties of all the hits, in almost the totality of cases the connection with actual 
protein aggregation appears as loose as seen above for the human molecules (subunits in oligomeric 
proteins, protein components in supramolecular assemblies; chaperones preventing protein 
aggregation; proteins involved in organelle or cell aggregation; etcetera). As it may be expected, 
contrary to the human entries, no reference is made to pathologies or to natural mutants; in few cases 
it is made to mutagenesis or to an experimentally null phenotype (Table 39). 
 
Table 39: Number of proteins forming aggregates per animal species 
Common name Genus and species Number of proteins 
laboratory animals:  
mouse 
rat 
African clawed frog 
zebrafish 
guinea pig 
 
Mus musculus 
Rattus norvegicus 
Xenopus levis 
Danio rerio 
Cavia porcellus 
 
151 
91 
19 
10 
7 
farm animals:  
bovine 
chicken 
pig 
rabbit 
horse 
sheep 
goat 
 
Bos taurus 
Gallus gallus 
Sus scrofa 
Oryctolagus cuniculus 
Equus caballus 
Ovis aries 
Capra hircus 
 
56 
19 
17 
11 
7 
7 
1 
pets:  
dog 
hamster 
cat 
 
Canis familiaris 
Mesocricetus auratus 
Felis catus 
 
10 
8 
5 
primates: 
Cynomolgus monkey 
Chimpanzee  
Japanese macaque 
Rhesus macaque 
 
Macaca fascicularis 
Pan troglodytes 
Macaca fuscata fuscata  
Macaca mulatta 
 
14 
4 
2 
2 
As an example, PrP was captured 41 times. 
In conclusion, summing up the overall evidence from this part of the work the words ‘toxic’ and ‘toxicity’ 
appear to be used sometimes in the scientific literature as synonyms of pathological/pathology or even 
of pathology-associated/pathology-associated phenomena. A similarly extended use up to improperly 
stretching and almost subverting the meaning occurs for aggregation when applied to proteins: as 
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written few lines above, the word is sometimes used as synonym of interaction, or binding, or complex 
formation, or polymerization.  
In addition to these mainly semantic observations, a biological issue seems relevant as well: while 
insoluble proteins, in the form of either amyloid fibers or amorphous aggregates, are observed in a 
number of diseases, the link between the presence of such insoluble structure and the pathogenesis of 
the disorder is not always clear. Efforts to prevent the formation of amyloid was effective in preventing 
neurological sequels in carriers of amyloidogenic transthyretin variants but interference on beta-amyloid 
processing had little impact on the development of Alzheimer disease. This raises the hypothesis that, 
at least in some cases, amyloid formation may be just a symptom/a marker of an ongoing condition 
rather than its cause.  
4. Quality assurance of 3D structures 
4.1. Protein Data Bank 
Out of the more than 6000 proteins identified with the “toxin activity” search, 738 have associated one 
or more experimentally-solved structure/s. On the other hand, 102 proteins have associated one or 
more experimentally-solved structures that were identified with the “toxin-antitoxin system” search. As 
described in the Materials and methods section of present report, 3D structures were carefully checked 
and only one experimentally-solved structure was selected for each protein. The selection criteria were 
based both on experimental determination of the structure and on resolution, weighting these two terms 
80% and 20%, respectively. 
The preparation of the structures via in silico methods (e.g. energy minimization, loop modelling and 
protonation) ensures that all the experimentally-solved related errors were corrected and that the 
selected structures are in an optimized geometry.  In order to show the distribution of some parameters, 
we use a boxplot5 graph obtained by reporting the 5 summary numbers [minimum, 1st quartile (Q1), 
median, 3rd quartile (Q3), maximum] on a vertical (or horizontal) axis.  As shown in Figure 39, the 
medians of the primary structure coverage are 89% and 100% for both Main Collection and TAS 
Collection, respectively. All selected 3D structures from the RCSB Protein Data Bank have a very good 
resolution (lower than 2.5 Å) (Figure 39), except one structure in the TAS Collection (higher than 8 Å), 
since in structures with resolution 3 Å or lower only the backbone of the protein chain is resolved with 
reasonable accuracy and the positions of the amino acid side chains are inferred based on predefined 
geometries. For the Main Collection, the interquartile range spans from 65% to 100%, a minimum is 
found around 15%, with some outliers. On the other hand, for the TAS Collection, the interquartile 
range is close to 100%, with many outliers.  
Overall, the selected experimentally-solved structures were considered of a good quality, considering 
both structural determination and resolution. All the outliers in structure determination (points in the 
boxplot) are related to proteins with a very long primary structure and the experimentally-solved protein 
parts are actually involved in the toxicological mechanism. In fact, for these proteins, the structural 
determination was focused on domains related to protein toxic effects, excluding structurally 
unstable/disordered regions. For the Main Collection, the median is 2 Å and the maximum is found 
around 3.5 Å, without outliers. On the other hand, for the TAS Collection, the median is approx. 1.5 Å, 
with an outlier. The single outlier shown in the resolution boxplot (Figure 40) represents a protein for 
which only the alpha-carbons of the protein were resolved (no side chains could be modelled). For this 
protein, a 3D model was generated using the MOE Homology Modelling tool. 
 
                                                 
5 The box of the plot has Q1 and Q3 respectively as lower and upper ends. The median divides the box into two parts. The 
moustache is obtained by joining Q1 to the minimum and Q3 to the maximum. The distance between Q3 and Q1 is called 
interquartile range. By comparing the lengths of the two whiskers (which represent the distances between Q1 and the minimum 
and between Q3 and the maximum) and the heights of the two rectangles that make up the box (which represent the distances 
between Q1 and median and between median and Q3) information on the symmetry of the distribution is obtained: this is all the 
more symmetrical as the lengths of the moustache are similar to each other and the heights of the two rectangles are similar to 
each other. The moustache also highlights the presence of any outliers (exceptional observations). 
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                                 Main Collection                                         TAS Collection 
Figure 39: Boxplot of the sequence coverage of the experimentally-solved structure for both Main and 
TAS Collections. The lower and the upper parts of the box represent the first and the third quartile, 
respectively, while the black line is the median. Points are outliers.  
 
 
                                  Main Collection                                       TAS Collection 
Figure 40: Boxplot of resolution of crystallographic structures for both Main and TAS Collections. The 
lower and the upper parts of the box represent the first and the third quartile, respectively, while the 
black line is the median. The point represents an outlier. 
4.1.1. Models downloaded from SM repository 
Swiss-Model, the protein structure homology-modelling server used to either download existing 3D 
model or to newly produce additional 3D models of protein toxins, has two different parameters for the 
model quality estimations: 
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i) GMQE (Global Model Quality Estimation) combines properties from the target–template 
alignment and the template search method. The resulting GMQE score is expressed as a number 
between 0 and 1, reflecting the expected accuracy of a model built with that alignment and 
template and the coverage of the target. Higher numbers indicate higher reliability. 
ii) Qmean is a composite estimator based on different geometrical properties and provides both 
global (i.e. for the entire structure) and local (i.e. per residue) absolute quality estimates on the 
basis of one single model. The QMEAN Z-score provides an estimate of the "degree of nativeness" 
of the structural features observed in the model on a global scale. It indicates whether the QMEAN 
score of the model is comparable to what one would expect from experimental structures of 
similar size. QMEAN Z-scores around zero indicate good agreement between the model structure 
and experimental structures of similar size. Scores of -4.0 or below are an indication of models 
with low quality.  
Both the GMQE and Qmean values were considered in the quality check of the obtained 3D models. As 
shown in Figures 41-44, the 3D structures downloaded from Swiss-Model repository have an acceptable 
GMQE value, while some of them have a low Qmean value (lower than -4.0).  
 
Figure 41: Scatterplot of Qmean and GMQE quality parameters for the Main Collection. 
 
 
Figure 42: Scatterplot of Qmean and GMQE quality parameters for the TAS Collection. 
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                                  Main Collection                                       TAS Collection 
Figure 43: Boxplot of model GMQE parameter for both Main and TAS databases. The lower and the 
upper parts of the box represent the first and the third quartile, respectively, while the black line is the 
median. The point represents an outlier. 
 
 
                                  Main Collection                                       TAS Collection 
Figure 44: Boxplot of model Qmean parameter for both Main and TAS databases. The lower and the 
upper parts of the box represent the first and the third quartile, respectively, while the black line is the 
median. The point represents an outlier. 
5. Evaluation of toxin prediction tools 
In parallel with the in silico pipeline developed to reach the milestones required by EFSA, we also tested 
the most important freely available toxin prediction tools (Table 41). These tools, developed by academic 
researchers, can be used to predict if a query protein could be a toxin and were selected starting from 
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a web search, also evaluating the available scientific literature. Obsolete or not documented tools were 
discarded.  
To test these tools, we selected some subsets of toxins from the Main or TAS Collection (as true 
positives) and some proteins known to be non-toxins (as true negatives). The true negatives were 
chosen among well-known proteins, not involved in toxicity and that are being studied by the UMIL 
group (Table 42). The tools were evaluated by computing the sensitivity, specificity and accuracy of the 
predictions. For some tools that predict toxicity in a specific field or for specific organisms, we also 
added a negative set, containing toxins that do not belong to the prediction field specific for the tool of 
interest (see below for further details). For each tool, we evaluated the Cooper’s statistic considering 
the parameter values in range (0.5-0.75] as fair; (0.75-0.95] as good; (0.95-0.99] as very good and 1 
as excellent. 
Table 41: Selected tools 
Source Link 
NTXpred http://crdd.osdd.net/raghava/ntxpred/ 
BTXpred http://crdd.osdd.net/raghava/btxpred/ 
KNOTTIN http://www.dsimb.inserm.fr/KNOTTIN/ 
CLANTOX http://www.clantox.cs.huji.ac.il 
CONOSERVER http://www.conoserver.org 
ToxinPred https://webs.iiitd.edu.in/raghava/toxinpred/index.html 
 
Table 42: Selected True Negative subset of well-known non-toxic proteins 
UniProtKB ID Protein Name Organism 
P60063 Arginine/agmatine antiporter Escherichia coli O157:H7 
Q01650 Large neutral amino acids transporter small subunit 1 Human 
P16301 Phosphatidylcholine-sterol acyltransferase Mouse 
Q00623 
Apolipoprotein A-I 
 
Mouse 
P10276 Retinoic acid receptor alpha Human 
Q9SD67 
ATP-dependent zinc metalloprotease FTSH 7, 
chloroplastic 
Arabidopsis thaliana 
Q09QM4 Uracil nucleotide/cysteinyl leukotriene receptor Rat 
P03372 Estrogen receptor Human 
P35869 Aryl hydrocarbon receptor Human 
P04629 High affinity nerve growth factor receptor Human 
Q15233 Non-POU domain-containing octamer-binding protein Human 
O43174 Cytochrome P450 26A1 Human 
Q9UKV0 Histone deacetylase 9 Human 
P08684 Cytochrome P450 3A4 Human 
P70041 Cerberus Xenopus laevis 
Q8MI17 Retinal dehydrogenase 1 Rabbit 
P28700 Retinoic acid receptor RXR-alpha Mouse 
Q00175 Progesterone receptor Mouse 
Q8C2B3 Histone deacetylase 7 Mouse 
P40394 All-trans-retinol dehydrogenase [NAD(+)] ADH7 Human 
 
5.1. NTXpred 
Link: http://crdd.osdd.net/raghava/ntxpred/ 
Neurotoxins are a broad class of exogenous chemical compounds that can adversely affect function in 
both developing and mature nervous tissues. Neurotoxins act on ion concentrations across the cell 
membrane, or synaptic communication between neurons. Neurotoxins are key players in science and 
medicine and are used in receptor studies, drug discovery and insecticides research. 
Literature search – Exploring in silico protein toxicity prediction methods to support food/feed RA 
 
 
 
www.efsa.europa.eu/publications 68 EFSA Supporting publication 2020: EN-1875 
The present document has been produced and adopted by the bodies identified above as authors. This task has been carried out exclusively by the authors 
in the context of a contract between the European Food Safety Authority and the authors, awarded following a tender procedure. The present document 
is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. 
The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present 
document, without prejudice to the rights of the authors). 
 
 
NTXpred allows users to discriminate between neurotoxins and non-toxins and to classify neurotoxin 
proteins on the basis of their function using a feed-forwarded neural network (FNN) and partial recurrent 
neural network (RNN) with a single hidden layer.  
The server can accept 2 types of primary structure format: 
1. amino acids in single letter code; 
2. a standard primary structure format (PIR, FASTA, EMBLE…). 
The user can select 4 different types of classification: 
1. neurotoxin or not neurotoxin; 
2. based on source; 
3. based on function; 
4. sub-classification of ion channel inhibitors. 
The server allows the prediction on the basis of 3 different approaches: 
1. amino acid composition (and length); 
2. dipeptide (and length); 
3. PSI-Blast. 
To test the performance of NTXpred, a true positive subset (TP) and two true negative subsets (TN1 
and TN2) of proteins were used. The proteins in the TP subset were randomly extracted from the Main 
Collection using an R script, selecting only proteins with the “Neurotoxin” keyword; the TN1 subset was 
created extracting proteins from the Main Collection, selecting only proteins with no associated 
neurotoxic effects. For TN2, protein listed in Table 42 were used. These proteins are not associated 
with any toxic effect. Tables 43-45 report the NTXpred results for the three used subsets.  
Table 43: NTXpred TP results 
UniProt ID NTXpred prediction 
(amino acid) 
NTXpred prediction 
(dipeptide) 
NTXpred prediction 
(PSI-BLAST) 
F1CGT6 Neurotoxin Neurotoxin Neurotoxin 
P0CI04 Neurotoxin Neurotoxin Neurotoxin 
P0C194 Neurotoxin Neurotoxin Neurotoxin 
P0DPI0 Neurotoxin Neurotoxin Neurotoxin 
A6YR42 Neurotoxin Neurotoxin Neurotoxin 
Q9BPC0 Neurotoxin Neurotoxin Neurotoxin 
P85273 Neurotoxin Neurotoxin Neurotoxin 
P45664 Neurotoxin Neurotoxin Neurotoxin 
D2Y218 Neurotoxin Neurotoxin Neurotoxin 
P84864 Neurotoxin Neurotoxin Neurotoxin 
Q6T178 Neurotoxin Neurotoxin Neurotoxin 
P58370 Neurotoxin Neurotoxin Neurotoxin 
P0DL24 Neurotoxin Neurotoxin Neurotoxin 
P86989 Neurotoxin Neurotoxin Neurotoxin 
A7X3V0 Neurotoxin Neurotoxin Neurotoxin 
Q98993 Non-toxin Non-toxin Non-toxin 
P0CB08 Neurotoxin Neurotoxin Neurotoxin 
Q9BPC7 Neurotoxin Neurotoxin Neurotoxin 
P84093 Neurotoxin Neurotoxin Neurotoxin 
P0C8E0 Neurotoxin Neurotoxin Neurotoxin 
 
Table 44: NTXpred TN1 results 
UniProt ID NTXpred prediction 
(amino acid) 
NTXpred prediction 
(dipeptide) 
NTXpred prediction 
(PSI-BLAST) 
Q0TV31 Non-toxin Non-toxin Non-toxin 
P83047 Non-toxin Non-toxin Non-toxin 
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D2Y225 Non-toxin Non-toxin Non-toxin 
P13423 Non-toxin Non-toxin Non-toxin 
P96622 Non-toxin Non-toxin Non-toxin 
Q07730 Non-toxin Non-toxin Non-toxin 
P09167 Non-toxin Non-toxin Non-toxin 
P0CE82 Non-toxin Non-toxin Non-toxin 
C0JAZ3 Non-toxin Non-toxin Non-toxin 
E3PQQ8 Non-toxin Non-toxin Non-toxin 
Q6STF1 Non-toxin Non-toxin Non-toxin 
O35126 Non-toxin Non-toxin Non-toxin 
Q0T963 Non-toxin Non-toxin Non-toxin 
P0DP16 Non-toxin Non-toxin Non-toxin 
P81428 Non-toxin Non-toxin Non-toxin 
Q9PTU8 Non-toxin Non-toxin Non-toxin 
P02879 Non-toxin Non-toxin Non-toxin 
P69840 Non-toxin Non-toxin Non-toxin 
P0C7B0 Non-toxin Non-toxin Non-toxin 
G8XQX1 Non-toxin Non-toxin Non-toxin 
 
Table 45: NTXpred TN2 results 
UniProt ID NTXpred prediction 
(amino acid) 
NTXpred prediction 
(dipeptide) 
NTXpred prediction 
(PSI-BLAST) 
P60063 Non-toxin Non-toxin Non-toxin 
Q01650 Non-toxin Non-toxin Non-toxin 
P16301 Non-toxin Non-toxin Non-toxin 
Q00623 Non-toxin Non-toxin Non-toxin 
P10276 Non-toxin Non-toxin Non-toxin 
Q9SD67 Non-toxin Non-toxin Non-toxin 
Q09QM4 Non-toxin Non-toxin Non-toxin 
P03372 Non-toxin Non-toxin Non-toxin 
P35869 Non-toxin Non-toxin Non-toxin 
P04629 Non-toxin Non-toxin Non-toxin 
Q15233 Non-toxin Non-toxin Non-toxin 
O43174 Non-toxin Non-toxin Non-toxin 
Q9UKV0 Non-toxin Non-toxin Non-toxin 
P08684 Non-toxin Non-toxin Non-toxin 
P70041 Non-toxin Non-toxin Non-toxin 
Q8MI17 Non-toxin Non-toxin Non-toxin 
P28700 Non-toxin Non-toxin Non-toxin 
Q00175 Non-toxin Non-toxin Non-toxin 
Q8C2B3 Non-toxin Non-toxin Non-toxin 
P40394 Non-toxin Non-toxin Non-toxin 
The web tool output is very simple, and easy to interpret. For each query, it indicates if the test protein 
is predicted to be a neurotoxin or not (Figures 45-46). For those proteins deemed as possible 
neurotoxins, NTXpred also provides a prediction of their cellular target and molecular function. NTXpred 
has very good sensitivity and excellent specificity and accuracy (Table 44). Based on our analysis, 
NTXpred appears to be a reliable tool in predicting neurotoxins.  
 
Figure 45: Extract of a positive results from the NTXpred webpage, using a sequence from TP dataset. 
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Figure 46: Extract of a negative results from the NTXpred webpage, using a sequence from TN2 
dataset. 
 
Table 46: NTXpred Cooper’ statistics (values between 0 and 1) 
Dataset Method Sensitivity Specificity Accuracy 
TP+TN1 
Amino acid 
0.95 1 1 
TP+TN2 0.95 1 1 
TP+TN1 
Dipeptide 
0.95 1 1 
TP+TN2 0.95 1 1 
TP+TN1 
PSI-BLAST 
0.95 1 1 
TP+TN2 0.95 1 1 
 
5.2. BTXpred 
Link: http://crdd.osdd.net/raghava/btxpred/ 
The BTXpred server accepts an amino acid sequence as input with the aim of predicting whether the 
queried protein is a bacterial toxin. If the protein is deemed as a bacterial toxin the tool also predicts 
its potential toxic function. The server also allows users to classify bacterial toxins into: 
- endotoxins (constituent of the cell wall released into host tissues when bacteria die) 
- exotoxins (soluble substance secreted into host tissues). 
Exotoxins are then classified into 7 different function groups depending upon their molecular targets: 
1. adenylate cyclase activation; 
2. guanylate cyclase activation; 
3. food poisoning; 
4. neurotoxins; 
5. macrophage cytotoxin; 
6. vacuolating cytotoxin; 
7. thiol-activated cytotoxin. 
The BTXpred server allows the submission of a sequence in any of the standard formats.  
The server allows 3 types of prediction: 
1. bacterial toxin or non-toxin; 
2. types of toxin – endotoxin or exotoxin; 
3. function of exotoxins. 
Moreover, the server allows the prediction on the basis of three different approaches: 
1. SVM (Support Vector Machine, for Toxin and types of toxin); 
2. PSI-Blast (for Toxin, Types of Toxin, and functions of exotoxins); 
3. HMM (Hidden Markov Model, only for function of exotoxins). 
To test the performance of BTXpred, a true positive subset (TP) and two true negative subsets (TN1 
and TN2) of proteins were used. The proteins in the TP subset were randomly extracted from the TAS 
Collection using an R script; the TN1 subset was created extracting random proteins from the Main 
Collection. For TN2, proteins listed in Table 42 were used. These proteins have not associated with any 
toxic effect. Tables 47-49 report the BTXpred results for the three used subsets.  
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Table 47: BTXpred TP results 
UniProt 
ID 
BTXpred prediction 
(amino acid 
composition – SVM) 
BTXpred prediction  
(dipeptide 
composition – SVM) Organism (Control) 
Q47156 Non-toxin Non-toxin Escherichia coli (strain K12) 
P76364 Bacterial toxin Non-toxin Escherichia coli (strain K12) 
Q49Z22 
Bacterial toxin 
Bacterial toxin 
Staphylococcus saprophyticus subsp. 
saprophyticus  
P9WIH6 
Bacterial toxin 
Non-toxin 
Mycobacterium tuberculosis (strain CDC 
1551 / Oshkosh) 
P11519 Bacterial toxin Non-toxin Escherichia coli (strain K12) 
O06777 
Bacterial toxin 
Non-toxin 
Mycobacterium tuberculosis (strain ATCC 
25618 / H37Rv) 
A1JUB1 Non-toxin Bacterial toxin 
Yersinia enterocolitica serotype O:8 / 
biotype 1B  
Q8U2Q8 Bacterial toxin Non-toxin Pyrococcus furiosus  
P9WII4 
Non-toxin 
Bacterial toxin 
Mycobacterium tuberculosis (strain CDC 
1551 / Oshkosh) 
L0TGF0 
Non-toxin 
Non-toxin 
Mycobacterium tuberculosis (strain ATCC 
25618 / H37Rv) 
P9WFA4 
Bacterial toxin 
Non-toxin 
Mycobacterium tuberculosis (strain CDC 
1551 / Oshkosh) 
Q06259 Bacterial toxin Bacterial toxin Escherichia phage P1 
Q52042 Bacterial toxin Bacterial toxin Escherichia coli 
P22995 Bacterial toxin Non-toxin Escherichia coli 
Q54944 Non-toxin Non-toxin Streptococcus pyogenes 
P9WFB9 
Non-toxin 
Non-toxin 
Mycobacterium tuberculosis (strain ATCC 
25618 / H37Rv) 
P64595 Non-toxin Non-toxin Escherichia coli O157:H7 
Q46953 Non-toxin Non-toxin Escherichia coli (strain K12) 
Q38278 Bacterial toxin Bacterial toxin Lactococcus phage c2 
P96621 bacterial toxin Non-toxin Bacillus subtilis (strain 168) 
 
Table 48: BTXpred TN1 results 
UniProt ID BTXpred prediction 
(Amino acid composition - 
SVM) 
BTXpred prediction 
(dipeptide composition - 
SVM) Organism (Control) 
U5L3M7 Bacterial toxin Bacterial toxin Amanita exitialis 
F5C3U4 Non-toxin Non-toxin Conus marmoreus 
C0JB52 Bacterial toxin Bacterial toxin Sicarius patagonicus 
A6YR37 Bacterial toxin Bacterial toxin Californiconus californicus 
C0JB68 Bacterial toxin Non-toxin Sicarius patagonicus 
P01519 Bacterial toxin Bacterial toxin Conus geographus 
E0SDG8 Bacterial toxin Bacterial toxin Dickeya dadantii (strain 3937) 
P86470 Bacterial toxin Non-toxin Bunodosoma caissarum 
P86544 Bacterial toxin Bacterial toxin Naja naja 
P0CH14 Bacterial toxin Non-toxin Conus marmoreus 
A6YR23 Bacterial toxin Bacterial toxin Californiconus californicus 
P28878 Bacterial toxin Bacterial toxin Conus striatus 
C0HKZ8 Bacterial toxin Bacterial toxin Walterinnesia aegyptia 
Q7T2I1 Bacterial toxin Non-toxin Laticauda laticaudata 
D2Y3T8 Bacterial toxin Bacterial toxin Californiconus californicus 
C0HL53 Bacterial toxin Bacterial toxin Heteractis crispa 
P0DMY5 Bacterial toxin Non-toxin Anemonia viridis 
P0C6S2 Bacterial toxin Bacterial toxin Conus cancellatus 
C0JB27 Bacterial toxin Bacterial toxin Loxosceles laeta 
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C0JB36 Bacterial toxin Bacterial toxin Sicarius peruensis 
 
Table 49: BTXpred TN2 results 
UniProt ID BTXpred prediction (Amino acid 
composition - SVM) 
BTXpred prediction (dipeptide 
composition - SVM) 
P60063 Non-toxin Non-toxin 
Q01650 Non-toxin Non-toxin 
P16301 Non-toxin Non-toxin 
Q00623 Non-toxin Non-toxin 
P10276 Non-toxin Non-toxin 
Q9SD67 Non-toxin Non-toxin 
Q09QM4 Non-toxin Non-toxin 
P03372 Non-toxin Non-toxin 
P35869 Non-toxin Non-toxin 
P04629 Non-toxin Non-toxin 
Q15233 Non-toxin Non-toxin 
O43174 Non-toxin Non-toxin 
Q9UKV0 Non-toxin Non-toxin 
P08684 Non-toxin Non-toxin 
P70041 Non-toxin Non-toxin 
Q8MI17 Non-toxin Non-toxin 
P28700 Non-toxin Non-toxin 
Q00175 Non-toxin Non-toxin 
Q8C2B3 Non-toxin Non-toxin 
P40394 Non-toxin Non-toxin 
The web tool produces the same output as NTXpred (Figures 47, 48). For each query, it warns if the 
test protein is a bacterial toxin or not. Differently from NTXpred, BTXpred does not provide predictions 
for cellular target(s) or molecular function. Sensitivity, specificity and accuracy show that BTXpred is 
able to reliably predict non-toxic proteins (Table 50) but has a reduced ability in discriminating between 
animal and bacterial toxins. Its sensitivity is fair, and accuracy using the TN1 dataset is unacceptably 
low (<0.5), using both amino acid- and dipeptide-based methods. In fact, the accuracy for TP+TN1 
databases is lower than the probability to predict if a toxin is bacterial toxin using an unbiased coin.  
 
Figure 47: Extract of a positive results from the BTXpred webpage, using a sequence from TP dataset. 
 
 
Figure 48: Extract of a negative results from the BTXpred webpage, using a sequence from TN2 
dataset. 
 
Table 50: BTXpred Cooper’ statistics (values between 0 and 1) 
Dataset Method Sensitivity Specificity Accuracy 
TP+TN1 
Amino acid (SVM) 
0.6 0.05 0.3 
TP+TN2 0.6 1 0.8 
TP+TN1 
Dipeptide (SVM) 
0.3 0.25 0.275 
TP+TN2 0.3 1 0.65 
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5.3. Knottin 
Link: http://www.dsimb.inserm.fr/KNOTTIN/ 
Knottins (sometimes referred as “Inhibitor Cysteine Knots”) are small disulphide-rich proteins containing 
at least 3 disulphide bridges and characterized by a disulphide through disulphide “knot”, formed when 
one disulphide bridge crosses the macrocycle formed by the two other disulphides and the 
interconnecting backbone. The structural family of knottins has the disulphide between cysteines III 
and VI going through disulphides I-IV and II-V (http://www.dsimb.inserm.fr/KNOTTIN/) (Figure 49). 
 
 
Figure 49: Crystal structure of asteropsin A from marine sponge Asteropus sp. (PDB ID: 3Q8J); the 
three disulphides bridges are highlighted. 
The connection between cysteines is very important: some small disulphide-rich proteins may resemble 
knottins, but are not considered as knottins because they do not contain the “knot”; some other types 
of proteins (for example the growth factor cysteine knots) may contain a knot but the connectivity is 
different, so they belong to a distinct structural family (Postic et al., 2018).  
The Knottin database is a relational database that stores information on known structures and 
sequences extracted from the Protein Data Bank and the UniProtKB. The section “Tools” allows users 
to select if a test protein is predicted to be a knottin based on its amino acid sequence (KNOTER1D) or 
its 3D structure (KNOTER3D). KNOTER3D was not assessed for consistency with other database tests. 
The text below refers only to KNOTER1D. KNOTER1D works as follow: 
i) the UniProtKB is filtered for cysteine-rich proteins; 
ii) each query sequence (seq1) is compared to all known knottin sequences (knot_seq2) using 
a similarity score based on:  
 the BLAST P-value for the seq1/knot_seq2 comparison; 
 the number of conserved cysteines of the knot when aligning seq1 onto the multiple 
alignment of the family of knot_seq2; 
 the compatibility of intercysteine loop lengths with known knottin loop lengths; 
 the taxonomic proximity between seq1 and knot_seq2; 
 the similarity between the seq1 function and knottin functions; 
 the similarity between seq1 keywords and knottin keywords, and/or dissimilarity 
between seq1 keywords and non-knottin keywords.  
The query sequence is analysed using BLAST to compare the sequence against the Knottin database. 
The results of the analysis of the server provide the user with the indication of whether the query 
sequence is predicted to be a knottin, a putative knottin or not a knottin, on the basis of similarity score 
(Figure 50-51).  
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Figure 50: Extract of some positive results from the Knottin webpage, using a sequence from TP 
dataset. 
 
Figure 51: Extract of some negative results from the Knottin webpage, using a sequence from TN 
dataset. 
To test the performance of KNOTTIN, a true positive subset (TP) and two true negative subsets (TN1 
and TN2) of proteins were used. The proteins in the TP subset were randomly extracted from the Main 
Collection using an R script, selecting only proteins with the “Knottin” keyword; the TN1 subset was 
created extracting proteins from the Main Collection, selecting only proteins that are not knottins. For 
TN2, proteins listed in Table 42 were used. These proteins are not associated with any toxic effect. 
Tables 51-53 report the KNOTTIN results for the three used subsets.  
 
Table 51: KNOTTIN TP results 
UniProt ID KNOTTIN prediction 
P83257 Putative knottin 
P0C8M0 Knottin 
P0C2L8 Putative knottin 
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P28881 putative knottin 
P85264 Not a knottin 
P0DL48 Not a knottin 
D2Y1Y6 knottin 
W4VSI3 Putative knottin 
D2Y2P8 Knottin 
B1P1F0 Knottin 
P61789 Putative knottin 
B3FIS3 Knottin 
D2Y2I9 Not a knottin 
P83400 Knottin 
Q5Y4W2 Knottin 
D2Y1Z6 Knottin 
P37045 Knottin 
D2Y267 Knottin 
P0CH13 Putative knottin 
Q9BP95 Putative knottin 
 
Table 52: KNOTTIN TN1 results 
UniProt ID KNOTTIN prediction 
P08434 is not a knottin  
P0DJP8 is not a knottin  
A8S6A4 is not a knottin  
P59938 is not a knottin  
P89059 is not a knottin  
Q9DEZ9 is not a knottin  
P0C201 knottin 
B2KKV7 is not a knottin  
P0DPU4 is not a knottin  
C0HJI9 is not a knottin  
D2Y2M5 knottin 
Q9YGC7 is not a knottin  
O06014 is not a knottin  
E5AJX2 is not a knottin  
Q3SAF4 is not a knottin  
Q3HXY4 is not a knottin  
D2Y2D4 is not a knottin  
P0C828 is not a knottin  
A0S865 is not a knottin  
B3FIS5 knottin 
 
Table 53: KNOTTIN TN2 results 
UniProt ID KNOTTIN prediction 
P60063 is not a knottin  
Q01650 is not a knottin  
P16301 is not a knottin  
Q00623 is not a knottin  
P10276 is not a knottin  
Q9SD67 is not a knottin  
Q09QM4 is not a knottin  
P03372 is not a knottin  
P35869 is not a knottin  
P04629 is not a knottin  
Q15233 is not a knottin  
O43174 is not a knottin  
Literature search – Exploring in silico protein toxicity prediction methods to support food/feed RA 
 
 
 
www.efsa.europa.eu/publications 76 EFSA Supporting publication 2020: EN-1875 
The present document has been produced and adopted by the bodies identified above as authors. This task has been carried out exclusively by the authors 
in the context of a contract between the European Food Safety Authority and the authors, awarded following a tender procedure. The present document 
is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. 
The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present 
document, without prejudice to the rights of the authors). 
 
 
Q9UKV0 is not a knottin  
P08684 is not a knottin  
P70041 is not a knottin  
Q8MI17 is not a knottin  
P28700 is not a knottin  
Q00175 is not a knottin  
Q8C2B3 is not a knottin  
P40394 is not a knottin  
 
We tested only the 1D prediction, in order to directly compare KNOTTIN’s ability to predict toxicity using 
the primary structure. Sensitivity, specificity and accuracy calculations show that KNOTTIN is a very 
good predictor in discriminating between nontoxic proteins and knottins when taking the more 
conservative approach (putative knottin = knottin), while it is less reliable if the less conservative 
approach (putative knottin = non-knottin) is taken (Table 54). Overall, accuracy is good. The user 
interface is very user-friendly and also the results are simple to interpret. 
 
Table 54: KNOTTIN Cooper’ statistics (values between 0 and 1) 
Dataset Method Sensitivity Specificity Accuracy 
TP+TN1 
Less conservative 
0.5 0.85 0.675 
TP+TN2 0.5 1 0.75 
TP+TN1 
More conservative 
0.85 0.85 0.85 
TP+TN2 0.85 1 0.925 
 
5.4. CLANTOX 
Link: http://www.clantox.cs.huji.ac.il/ 
ClanTox is a classifier of animal toxins. It is based on the extraction of sequence-driven functions from 
the primary protein sequence followed by the application of a classification system. This tool predicts 
whether a given sequence is similar to a toxin. 
Queries in ClanTox are first transformed into a vector on the basis of various features extracted from 
the sequence and then analysed by ten sub-classifiers using specific algorithms. As a result, each 
classifier will produce a slightly different prediction:  
i) class P3 ("Toxin-like") 
ii) class P2 ("Probably toxin-like") 
iii) class P1 ("Possibly toxin-like")  
iv) class N ("Probably not toxin-like") 
The labels P1, P2 and P3 are considered positive (i.e. either toxin or toxin-like) while the label N is 
considered negative (non-toxins). The mean score and standard deviation correspond to the average 
and standard deviation of all ten predictions.  
To test the performance of Clantox, a true positive subset (TP) and two true negative subsets (TN1 and 
TN2) of proteins were used. The proteins in the TP subset were randomly extracted from the Main 
Collection using an R script, verifying that all the selected entries are animal proteins; the TN1 subset 
was created extracting proteins from the TAS Collection. For TN2, proteins listed in Table 42 were used. 
These proteins are not associated with any toxic effect. Table 55-57 reports the Clantox results for the 
three used subsets.  
 
Table 55: Clantox TP results 
UniProt ID Clantox prediction Organism 
P0C1U0 Toxin-like Conus consors 
P50984 Probably toxin-like Conus pennaceus 
C0JAV6 Probably not toxin-like Loxosceles apachea 
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P0DMA1 Toxin-like Conus pictus 
D0PX84 Possibly toxin-like Conus imperialis 
Q8UW25 Probably not toxin-like Hydrophis hardwickii 
P0DMY1 Toxin-like Anemonia viridis 
C0JB45 Probably not toxin-like Loxosceles spinulosa 
P84823 Probably not toxin-like Ascaphus truei 
A0A2I6EDL6 Possibly toxin-like Conus regius 
P0DM28 Probably not toxin-like Conus spurius 
P0C7J9 Probably not toxin-like Crotalus adamanteus 
P0DPM0 Possibly toxin-like Conus stercusmuscarum 
Q9BPH3 Possibly toxin-like Conus arenatus 
P01386 Toxin-like Ophiophagus hannah 
A0A1P8NVT3 Possibly toxin-like Conus frigidus 
Q1W694 Probably not toxin-like Loxosceles intermedia 
P86721 Probably not toxin-like Bothrops atrox 
P0C8V4 Probably toxin-like Conus ventricosus 
Q86DU6 ? Conus striatus 
 
Table 56: Clantox TN1 results 
UniProt ID Clantox prediction Organism 
Q47156 Probably not toxin-like Escherichia coli (strain K12) 
P76364 Probably not toxin-like Escherichia coli (strain K12) 
Q49Z22 Probably not toxin-like Staphylococcus saprophyticus  
P9WIH6 Probably not toxin-like Mycobacterium tuberculosis 
P11519 Probably not toxin-like Escherichia coli (strain K12) 
O06777 Probably not toxin-like Mycobacterium tuberculosis  
A1JUB1 Probably not toxin-like Yersinia enterocolitica serotype O:8  
Q8U2Q8 Probably not toxin-like Pyrococcus furiosus  
P9WII4 Probably not toxin-like Mycobacterium tuberculosis  
L0TGF0 Probably not toxin-like Mycobacterium tuberculosis  
P9WFA4 Probably not toxin-like Mycobacterium tuberculosis  
Q06259 Probably not toxin-like Escherichia phage P1 
Q52042 Probably not toxin-like Escherichia coli 
P22995 Probably not toxin-like Escherichia coli 
Q54944 Probably not toxin-like Streptococcus pyogenes 
P9WFB9 Probably not toxin-like Mycobacterium tuberculosis  
P64595 Probably not toxin-like Escherichia coli O157:H7 
Q46953 Probably not toxin-like Escherichia coli (strain K12) 
Q38278 Probably not toxin-like Lactococcus phage c2 
P96621 ? Bacillus subtilis (strain 168) 
 
Table 57: Clantox TN2 results 
UniProt ID Clantox prediction 
P60063 Probably not toxin-like 
Q01650 Probably not toxin-like 
P16301 Probably not toxin-like 
Q00623 Probably not toxin-like 
P10276 Probably not toxin-like 
Q9SD67 Probably not toxin-like 
Q09QM4 Probably not toxin-like 
P03372 Probably not toxin-like 
P35869 Probably not toxin-like 
P04629 Probably not toxin-like 
Q15233 Probably not toxin-like 
O43174 Probably not toxin-like 
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Q9UKV0 Probably not toxin-like 
P08684 Probably not toxin-like 
P70041 Probably not toxin-like 
Q8MI17 Probably not toxin-like 
P28700 Probably not toxin-like 
Q00175 Probably not toxin-like 
Q8C2B3 Probably not toxin-like 
P40394 ? 
During the test, the last sequence of the dataset was not read by the web tool (prediction = “?”). 
 
The web tool output is very simple and easy to interpret. ClanTox categorizes proteins into 4 different 
levels of prediction. For each query, it indicates if it is an animal toxin or not (Figures 52-53). To evaluate 
the results, we followed an “increasing conservatism” approach as follows: 
i) less conservative approach: only the proteins classified as P3 ("Toxin-like") are 
considered as toxins; 
ii) conservative approach: only the proteins classified as P3 and P2 ("Probably toxin-
like") are considered as toxins;  
iii) more conservative approach: the proteins classified as P3 ("Toxin-like"), P2 
("Probably toxin-like") or P1 ("Possibly toxin-like") are considered as toxins. 
ClanTox has acceptable sensitivity and a good accuracy in the more conservative and conservative 
approaches. In the less conservative approach, it has an unacceptable sensitivity (<0.5). Specificity is 
excellent in all the three approaches (Table 58).  
 
 
Figure 52: Extract of some positive results from the ClanTox webpage, using the TN dataset. 
Literature search – Exploring in silico protein toxicity prediction methods to support food/feed RA 
 
 
 
www.efsa.europa.eu/publications 79 EFSA Supporting publication 2020: EN-1875 
The present document has been produced and adopted by the bodies identified above as authors. This task has been carried out exclusively by the authors 
in the context of a contract between the European Food Safety Authority and the authors, awarded following a tender procedure. The present document 
is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. 
The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present 
document, without prejudice to the rights of the authors). 
 
 
 
 
Figure 53: Extract of some positive results from the ClanTox webpage, using the TN dataset. 
 
Table 58: Clantox Cooper’ statistics (values between 0 and 1) 
Dataset Method Sensitivity Specificity Accuracy 
TP+TN1 
Less conservative 
0.2 1 0.6 
TP+TN2 0.2 1 0.6 
TP+TN1 
Conservative 
0.5 1 0.76 
TP+TN2 0.5 1 0.76 
TP+TN1 
More conservative 
0.6 1 0.8 
TP+TN2 0.6 1 0.8 
 
5.5. ConoServer 
Link: http://www.conoserver.org/ 
ConoServer is a database containing information on toxins found in the Conidae family (cone snails) of 
predatory sea snails; these toxins are known as conotoxins or conopeptides. Conotoxins are 10 to 30 
amino acid long and usually contain one or more disulphide bonds. The evidence for their function is 
not clear however it appears that many of them modulate the activity of ion channels via mechanisms 
of action that seem to vary (Kaas et al., 2012). Because of their high specificity and affinity towards 
human ion channels, receptors and transporters of the nervous system, conopeptides are of significant 
importance to medical research: their features make them both an interesting tool for physiology studies 
on neuroreceptors and promising drug leads (Kaas et al., 2012). ConoServer contains information on 
protein sequences, nucleic acid sequences and structural information of conopeptides. ConoServer's 
data are first collected from the peer-reviewed literature and from publicly available databases, including 
UniProtKB/Swiss-Prot, NCBI nucleotide (nt), and the World-Wide Protein Data Bank. 
To test the performance of ConoServer, a true positive subset (TP) and two true negative subsets (TN1 
and TN2) of proteins were used. The proteins in the TP subset were randomly extracted from the Main 
Collection using an R script, verifying that all the selected entries are conotoxins; the TN1 subset was 
created extracting non-conotoxins proteins from the Main Collection. For TN2, proteins listed in Table 
42 were used. These proteins are not associated with any toxic effect. Tables 59-61 report the 
ConoServer results for the three used subsets.  
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Table 59: ConoServer TP results 
UniProt ID ConoServer prediction 
Q5K0D6 Conotoxin 
Q9BPI5 Conotoxin 
Q9BP84 Conotoxin 
Q9XZL5 Conotoxin 
Q9BP68 Conotoxin 
Q9UAB2 Conotoxin 
P0C831 Conotoxin 
P0C8V8 Conotoxin 
Q5EHP2 Conotoxin 
Q9BPB9 Conotoxin 
P0DJC7 Conotoxin 
P0C1N1 Conotoxin 
Q9BP80 Conotoxin 
D6C4L7 Conotoxin 
Q2I2R3 Conotoxin 
P69751 Conotoxin 
C8CK74 Conotoxin 
Q9BPC1 Conotoxin 
Q2I2Q2 Conotoxin 
Q9N6A4 Conotoxin 
 
Table 60: ConoServer TN1 results 
UniProt ID ConoServer prediction 
P82683 No 
C0JB41 No 
P81428 No 
P13495 No 
P0A376 No 
Q9PVF0 No 
C9X4K7 No 
Q45718 No 
Q98957 No 
P43445 No 
A7X3X3 No 
F8S0Y4 No 
P59867 No 
C5H5D1 No 
P19321 No 
P82981 No 
P0A377 No 
P00629 No 
D2Y292 No 
P15228 No 
 
Table 61: ConoServer TN2 results 
UniProt ID ConServer prediction 
P60063 No 
Q01650 No 
P16301 No 
Q00623 No 
P10276 No 
Q9SD67 No 
Q09QM4 No 
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P03372 No 
P35869 No 
P04629 No 
Q15233 No 
O43174 No 
Q9UKV0 No 
P08684 No 
P70041 No 
Q8MI17 No 
P28700 No 
Q00175 No 
Q8C2B3 No 
P40394 No 
 
 
Figure 54: Extract of some positive results from the ConoServer webpage. 
 
  
 
Figure 55: Extract of some negative results from the ConoServer webpage. 
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ConoServer accepts a single sequence as input. The produced output is very simple, and easy to 
interpret (Figures 54-55) and it shows outstanding accuracy in discriminating between conotoxins and 
non-conotoxins (Table 62). The Cooper’s statistic is excellent. 
 
Table 62: ConoServer Cooper’ statistics (values are between 0 and 1) 
Dataset Sensitivity Specificity Accuracy 
TP+TN1 1 1 1 
TP+TN2 1 1 1 
 
5.6. ToxinPred 
Link: https://webs.iiitd.edu.in/raghava/toxinpred/index.html 
ToxinPred is an in silico tool to predict toxicity of peptides/proteins starting from their primary structure 
(Figures 56, 57), also identifying specific toxic regions in proteins. ToxinPred was trained using a 
database created by extracting small toxins proteins/peptides from different databases including ATDB, 
Arachno-Server, Conoserver, DBETH, BTXpred, NTXpred and SwissProt. To build prediction models, 
ToxinPred uses Support Vector Machine (SVM), based on a freely available machine learning method; 
its performance was evaluated on independent datasets. The identification of possible motifs in toxins 
was based on MEME (Multiple Em for Motif Elicitation): this tool was used to assign unknown sequences 
as toxic or non-toxic by scanning known toxicity-associated motifs, using another application of the 
MEME suite called Motif Alignment & Search Tool (MAST). The hybrid approach, which combines motif 
identification with SVM output, offers an extra advantage for a more biologically reliable prediction of 
toxic peptides.  
The true positive subset (TP) used to test the performance of ToxinPred was randomly extracted from 
Main Collection, using an R script. The true negative subset (TN) was composed by proteins listed in 
Table 42. The output is very simple, and easy to interpret. ToxinPred accepts a single sequence as input 
and shows a good accuracy in discriminating between toxins and non-toxins, a good specificity and a 
fair sensitivity (Tables 63-65).  
 
Table 63: ToxinPred TP results 
UniProt ID ToxinPred prediction 
Q7LZ09 Non-Toxin 
P0C8B6 Non-Toxin 
P85011 Toxin 
B3EWW9 Non-Toxin 
P0C6S6 Non-Toxin 
P0C7K1 Toxin 
A0A023UBA8 Non-Toxin 
P85224 Non-Toxin 
P20416 Toxin 
P86255 Toxin 
P56855 Toxin 
P85277 Toxin 
P0DKX1 Non-Toxin 
A8W7N4 Non-Toxin 
P61508 Toxin 
P0C7J9 Toxin 
P0C349 Toxin 
P0DOZ5 Toxin 
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Table 64: ToxinPred TN results 
UniProt ID ToxinPred prediction 
P37817 Non-Toxin 
Q8IVG9 Non-Toxin 
E3YBA4 Toxin 
P62945 Non-Toxin 
P13191 Non-Toxin 
P36937 Non-Toxin 
C0HJF7 Non-Toxin 
P83835 Non-Toxin 
P84643 Non-Toxin 
Q9NRI7 Non-Toxin 
P84384 Non-Toxin 
P85170 Non-Toxin 
P80056 Non-Toxin 
P16312 Non-Toxin 
P83951 Non-Toxin 
P58020 Non-Toxin 
P0CH48 Non-Toxin 
P0DMB9 Non-Toxin 
 
 
Figure 56: Extract of a positive results from the ToxinPred webpage, using a sequence from TP dataset. 
 
 
Figure 57: Extract of a negative results from the ToxinPred webpage, using a sequence from TN 
dataset. 
 
Table 65: ToxinPred Cooper’ statistics (values are between 0 and 1) 
Dataset Sensitivity Specificity Accuracy 
TP+TN 0.6 0.95 0.78 
 
6. Evaluation of other freely available tools 
6.1. Meme 
The MEME tool identifies motifs in sequences, splitting variable-length patterns into two or more 
separate motifs. A motif in MEME is defined as an approximate sequence pattern that occurs repeatedly 
in a group of related sequences. The motifs representation is very simple to interpret because MEME is 
based on position-dependent letter-probability matrices that describe the probability of each possible 
letter at each position in the pattern. MEME accepts as input a group of sequences in FASTA format and 
outputs as many motifs as requested by the user, reporting the best width, number of occurrences, and 
description for each motif. MEME is available both as an online tool and as a downloadable locally 
installed program. The standard output is an .html file (Figure 58), containing all the results in a human-
readable format and an .xml file for further machine processing. MEME is simple to use, and it may also 
be integrated into an automated in silico pipeline 
A Meme search was performed using both the Main and TAS Collections (results not provided) in order 
to identify motifs for each family/domain as defined in the relevant databases used for this work (see 
Table 4). 
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Figure 58: Example of a MEME discovered motif output. ACD domain from PROSITE was taken as 
example. 
 
7. Discussion, conclusions and future perspectives 
This work presents the outcome of a comprehensive search in peer-reviewed literature and in public 
protein databases designed to identify and retrieve information published on proteins with associated 
toxic effects in humans and animals (mammals, fish and birds). Our work addressed separately 1) toxic 
protein, i.e. proteins showing toxic activity either per se or as part of a toxin-antitoxin system, and 2) 
proteins prone to form endogenous aggregates in humans and animals and associated to disease. 
For toxic proteins we adopted an integrated search strategy. Using the primary search string “toxin 
activity” on both protein (UniProtKB) and literature (WoS, SCOPUS and Pubmed) databases we found 
6,964 proteins. By applying a growing strategy using the secondary search string “toxin-antitoxin 
system” we found an additional 627 proteins. Accordingly, we created two Collections to group the 
results from the two searches. For all the identified proteins, relevant toxicity information (e.g. GOs, 
keywords, source organism) was retrieved from UniProtKB and clustered. Excel tables were created for 
each Collection in order to summarise both data and related literature and to provide “raw” data to the 
user. The pathogenesis leading to the adverse effect(s) was also described for each toxin, and 
information on the underlying molecular mechanism of action(s) was collected and annexed to both 
Collections. UniProtKB unique IDs were used to manage all the information, classifying each toxic protein 
through this tag. The integrated strategy applied allowed us to reach the milestone of a comprehensive 
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literature search of proteins with well-recognized toxic activity. A Python-based automated tool (script) 
was developed to retrieve information and facilitate the management of the whole pipeline.  
3D experimentally-determined and predicted (modelled) structures were also collected respectively from 
the RCSB Protein Data Bank and from the Swiss-Model repository for proteins with sequence more than 
20 amino acids in length. We also computed novel 3D models when neither experimentally-determined 
structures nor already modelled 3D structures were available. Quality check of both experimentally-
determined structures and predicted models was carried out. All the 3D structures were refined via MOE 
tools to fill gaps or add missing atoms. With this in silico pipeline, we obtained, to the best of our 
knowledge, the first ‘complete set’ of the 3D structures of proteins with a well-recognised toxic activity. 
A comprehensive search was also performed to cluster selected toxins based on protein family 
classification as well as identified domains and other molecular signatures: eleven databases were 
queried for these analyses; family classification was retrieved from the Pfam database, while domains 
and signatures were obtained from InterPro. These two databases were considered as reference sources 
for the two types of information. On the basis of these classifications, sequence alignments were 
performed using primary structures of toxins belonging to the same family or having the same 
architecture (same domains). 3D structure superimpositions were also carried out, highlighting common 
features. This in silico and database-oriented strategy allowed us to reach the milestone of the 
comprehensive search of families, domains and signatures.   
Other freely available tools were also tested, in order to provide to EFSA an evaluation for the ability of 
these tools in discriminating between toxins and non-toxic proteins. The performance of these tools was 
assessed by computing Cooper’s statistics using different sub-sets of data.  
Proteins prone to form endogenous aggregates in humans and animals when in mutated form or 
expressed at abnormally high levels in a disease-state, or accumulated when inefficiently catabolized, 
do not fit into the definition of toxin as set by the GO database (protein that “interacts selectively with 
one or more biological molecules in another organism - the "target" organism). Their nature and 
behaviour were anyway investigated by manually inspecting their features as reported in the relevant 
UniProtKB entries. It was possible to verify that all these proteins (retrieved with keywords ‘amyloid’ 
and ‘aggregat*’) are physiological components of human/animal tissues and that aggregation occurs 
only under specific conditions. While aggregation is positively associated with disease, it is not clear if 
aggregates may be themselves the cause of the pathological events or the adverse effects may arise 
from the reduced availability of the native monomeric protein or because of several factors that may 
interact synergistically. 
Overall, this work features a literature search and an up-to-date collection of information on proteins 
associated with adverse (toxic) effects. All the evidence is gathered from databases that are considered 
reference sources by the scientific community. Reference databases for protein sequence, structure and 
activity and key literature databases were used. Thus, the implemented strategy described in this report 
highlighted the key protein information sources available and resulted in the production of two 
comprehensive and complementary “collections” of proteins associated with adverse (toxic) effects and 
related relevant information. 
Such collections can be an important reference set to support the risk assessment of novel or poorly 
characterised proteins. These can be mined for further investigations in several directions for either 
research or risk assessment purposes. For instance, structural data can be used for other in silico 
analyses, e.g. molecular docking and molecular dynamics simulations. This could provide an insight 
towards the understanding of the molecular initiating event (MIE) of toxicological pathways.  
The data collected in this work may contribute to the development of a comprehensive in silico risk 
assessment strategy and more in general can be the basis for setting new risk assessment strategies 
for new proteins. Methodologies could be devised and tested for sensitivity, specificity and accuracy, in 
a similar way to what has already been extensively done for chemicals. For example, homology detection 
can be performed for inferring (toxic) properties from well characterized biopolymers, since homologous 
proteins can share similar structural architecture and functions. 
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These data can also be used in conjunction with already available and well-established methods in 
protein science. For example, using ‘protein BLAST’ to analyse a protein sequence for similarity against 
toxic proteins and restricting the analysis to the identified proteins in the constructed Collections instead 
of the whole UniProtKB database, could increase the probability of identifying biologically significant 
similarities against known and well-annotated toxins. Additional strategies can be developed using the 
gathered data that are based on the use of multiple alignments, specific domains and/or molecular 
signatures as well as hidden Markov models (hMMs)-oriented approaches. Such strategies could be used 
to assess whether a protein belongs to a family that is known to contain toxic proteins. Moreover, 
artificial intelligence approaches could also be applied combining findings from methods such as the 
above-mentioned in order to try to increase the accuracy of predictive risk assessment for proteins. 
The data collected for this work can form the basis for further information gathering in order to identify 
those protein structural/functional elements relevant in the molecular initiating events leading to toxicity.  
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